JBC Publications

0
Publications

JBC Members in Bold

2024

  1. Nigrovic PA, de Benedetti F, Kimura Y, Lovell DJ, Vastert SJ. The elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset Still’s disease. Pediatr Rheumatol Online J. 2024 Jan 5;21(Suppl 1):114.
  2. Kawano Y, Wang X, Patel NJ, Qian G, Kowalski E, Bade KJ, Vanni KMM, Jonsson AH, Williams ZK, Cook CE, Srivatsan S, Wallace ZS*, Sparks JA*. Breakthrough COVID-19 after tixagevimab/cilgavimab among patients with systemic autoimmune rheumatic diseases. J Rheumatol. 2024 Mar 1;51(3):305-312. *Co-senior authors.
  3. Wang Q, Martínez-Bonet M, Kim T, Sparks JA, Ishigaki K, Chen X, Sudman M, Gutierrez-Arcelus M, Prahalad S, Raychaudhuri S, Weirauch MT, Langefeld CD, Thompson SD, Nigrovic PA. Identification of a regulatory pathway governing TRAF1 via an arthritis-associated non-coding variant. Cell Genom. 2024 Feb 14;4(2):100502.
  4. Doyle TJ, Juge PA, Peljto A, Lee S, Walts A, Esposito AJ, Poli de Frias S, Gill RR, Hatabu H, Nishino M, Dellaripa PF, Weinblatt ME, Shadick NA, Demoruelle MK, Sparks JA, Rosas IO, Granger B, Deane K, Crestani B, Wolters PJ, Dieude P, Lee JS. Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease. Thorax. 2024 Jan 18;79(2):182-185.
  5. Hanberg JS, Fu X, Wang X, Patel NJ, Kawano Y, Schiff A, Kowalski EN, Cook CE, Vanni KMM, Guzzo K, Qian G, Bade KJ, Saavedra A, Venkat R, Srivatsan S, Zhang Y, Sparks JA*, Wallace ZS*. Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: An emulated target trial. Lancet Rheumatol. 2024 Jan;6(1):e21-e30.*Co-senior authors.
  6. Mizuno S, Vadala G, Kang JD. Biological Therapeutic Modalities for Intervertebral Disc Diseases: An Orthoregeneration Network (ON) Foundation Review. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 2023 Oct 31. https://doi.org/10.1016/j.arthro.2023.10.032.
  7. Merino-Vico A, van Hamburg JP, Tuijnenburg P, Frazzei G, Al-Soudi A, Bonasia CG, Helder B, Rutgers A, Abdulahad WH, Stegeman CA, Sanders JS, Bergamaschi L, Lyons PA, Bijma T, van Keep L, Wesenhagen K, Jongejan A, Olsson H, de Vries N, Kuijpers TW, Heeringa P, Tas SW. Targeting NF-κB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis. J Autoimmun. 2023 Nov 4;142:103133. doi: 10.1016/j.jaut.2023.103133. Epub ahead of print. PMID: 37931331.
  8. Kang JB, Shen AZ, Gurajala S, Nathan A, Rumker L, Aguiar VRC, Valencia C, Lagattuta KA, Zhang F, Jonsson AH, Yazar S, Alquicira-Hernandez J, Khalili H, Ananthakrishnan AN, Jagadeesh K, Dey K, Accelerating Medicines Partnership Program: Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Network, Daly MJ, Xavier RJ, Donlin LT,  Anolik JH, Powell JE, Rao DA, Brenner MB, Gutierrez-Arcelus M, Luo Y, Sakaue S, Raychaudhuri S. Mapping the dynamic genetic regulatory architecture of HLA genes at single-cell resolution. Nature Genetics 55, 2255–2268 (2023). https://doi.org/10.1038/s41588-023-01586-6
  9. Schiff AE, Wang X, Patel NJ, Kawano Y, Hanberg J, Kowalski EN, Cook CE, Vanni KMM, Qian G, Bade KJ, Saavedra A, Srivatsan S, Williams ZK, Venkat RK, Wallace ZS*, Sparks JA*. Immunomodulators and risk for breakthrough COVID-19 after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis: A cohort study. Ann Rheum Dis. 2023 (In Press). *Contributed equally.
  10. Kronzer VL, Davis JM III, Hanson AC, Sparks JA, Myasoedova E, Ernste FC, Duarte-Garcia A, Hinze AH, Makol A, Koster MJ, Vassallo R, Warrington KJ, Wright K, Crowson CS. Association between sinusitis and incident rheumatic diseases: A population-based study. RMD Open. 2023 (In Press).
  11. Li Y, Choudhary MC, Regan J, Boucau J, Nathan A, Liew MY, Edelstein G, Kawano Y, Uddin R, Deo R, Marino C, Reynold Z, Barry M, Gilber RF, Tien D, Sagar S, Vyas TD, Flynn JP, Wallace ZS, Sparks JA, Seaman MS, Gaiha G, Siedner MJ, Barczak AK, Lemieux JE, Li JZ. Severe acute respiratory syndrome coronavirus 2 omicron and delta variant infection in immunocompromised and non-immunocompromised individuals: A cohort comparative study. Sci Trans Med. 2023 (In Press).
  12. Taubmann J, Müller F, Yalcin Mutlu M, Völkl S, Aigner M, Bozec A, Mackensen A, Grieshaber-Bouyer R, Schett G. CD19 CAR-T cell treatment: Unraveling the role of B cells in Systemic Lupus Erythematosus. Arthritis Rheumatol. 2023 Dec 19. https://doi.org/10.1002/art.42784
  13. Merkt W, Freitag M, Claus M, Kolb P, Falcone V, Röhrich, Rodon L, Deicher F, Andreeva I, Tretter T, Tykocinski LO, Blank Nm Watzl C, Schmitt A, Sauer T, Müller-Tidow C, Polke M, Heußel CP, Dreger P, Lorenz HM, Schmitt M. Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis. Annals of the Rheumatic Diseases Published Online First: 22 December 2023. doi: 10.1136/ard-2023-225174
  14. Charles JF, Malabanan AO, Krolczyk S, Dahir K. Rare causes of musculoskeletal pain: thinking beyond common rheumatologic diseases. Case Reports in Rheumatology, in press.
  15. Liu C, Seyok T, Moye S, Sugita L, Eltouny E, Carrera C, Denagamage P, Charles JF, Fitz W, Chen AF, Earp B. High Rates of Vitamin D Insufficiency among Patients Presenting for Total Knee Arthroplasty, JOR, in press
  16. Kim H, Liu Y, Kim J, Kim Y, Klouda T, Fisch S, Baek SH, Liu T, Dahlberg S, Hu CJ, Tian W, Jiang X, Kosmas K, Christou HA, Korman BD, Vargas SO, Wu JC, Stenmark KR, Perez V de J, Nicolls MR, Raby BA, Yuan K. Pericytes contribute to pulmonary vascular remodeling via HIF2α signaling. EMBO Rep. Published online January 19, 2024. doi:10.1038/s44319-023-00054-w
  17. Taiji R, Kang JD, Mizuno S. Cellular behavior and extracellular matrix turnover in bovine annulus fibrosus cells under hydrostatic pressure and deviatoric strain. J Orthop Res. 2024; 1-9. doi:10.1002/jor.25779
  18. Sparks JA. Pre-existing autoimmune diseases and immune checkpoint inhibitors for cancer treatment: Considerations about initiation, flares, immune-related adverse events, and cancer progression. Rheum Dis Clin. 2024 (In Press).
  19. Ladouceur A, Clifford A, Ezdoglian A, Jamal S, Hudson M, Sparks JA, Roberts J, Ye C. The utility of laboratory investigations for the assessment and management of rheumatic immune-related adverse events. Rheum Dis Clin. 2024 (In Press).
  20. Kronzer VL, Sparks JA, Raychaudhuri S, Cerhan JR. The promise of exome and genome sequencing for rheumatoid arthritis risk. Nat Rev Rheumatol. 2024 (In Press).
  21. Müller F*, Taubmann J*, Bucci L, Wilhelm A, Bergmann C, Völkl S, Aigner M, Rothe T, Minopoulou I, Tur C, Knitza J, Kharboutli S, Kretschmann S, Vasova I, Spoerl S, Reimann H, Munoz L, Gerlach RG, Schäfer S, Grieshaber-Bouyer R, Korganow AS, Farge-Bancel D, Mougiakakos D, Bozec A, Winkler T, Krönke G, Mackensen A*, Schett G*. A Case Series with Extended Follow-up of CD19-CAR-T Cell Therapy in Autoimmune Disease NEJM 2024. February 22, 2024. PMID: 38381673 DOI: https://doi.org/10.1056/NEJMoa2308917.
  22. Patel NJ, Wang X, Lin M, Kowalski EN, Cook CE, Vanni KMM, Guzzo K, Qian G, Bade KJ, Saavedra A, Venkat R, Srivatsan S, Williams ZK, Hanberg JS, Kawano Y, Schiff AE, Sparks JA*, Wallace ZS*. Factors associated with an electronic health record-based definition of post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic disease. J Rheumatol. 2024 (In Press). *Contributed equally.
  23. Kim T, Martínez-Bonet M, Wang Q, Sparks JA, Baglaenko Y, Koh BH, Darbousset R, Laza-Briviesca R, Chen X, Gutierrez-Arcelus M, Brenner MB, Westra HJ, Weirauch MT, Raychaudhuri S, Rao DA, Nigrovic PA. Non-coding autoimmune risk variant defines role for ICOS in T peripheral helper cell development. Nat Commun. 2024 Mar 9;15(1):2150. doi: 10.1038/s41467-024-46457-8.
  24. Nassar AH, El Zarif T, Khalid AB, Rahme S, Zhong C, Kwak L, Salame M, Farhat EB, Freeman D, El-Am E, Ravishankar A, Ahmad B, Nana FA, Kaldas D, Naqash AR, Sharon E, LeBoeuf N, Cortellini A, Malgeri A, Gupta S, Al-Hader A, Sparks JA, Linnoila J, Hamnvik OPR, Mouhieddine TH, Marron TU, Parikh K, McKay RR, Dilling T, Choueiri TK, Adib E, Najem E, Kim SY, Sonpavde GP. Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes. J Immunother Cancer. 2024 (In Press).
  25. Kronzer VL, Sparks JA, Raychaudhuri S, Cerhan JR. Low-frequency and rare genetic variants associations with rheumatoid arthritis risk. Nat Rev Rheumatol. 2024 (In Press).
  26. Juge PA, Dellaripa PF, Sparks JA. Pulmonary damage biomarkers for risk of rheumatoid arthritis-associated interstitial lung disease: Enabling early detection and risk stratification. Arthritis Rheumatol. 2024 Feb 15. doi: 10.1002/art.42827. Online ahead of print.
  27. McDermott GC, Sparks JA. Rheumatoid arthritis and bronchiectasis risk: Additional evidence linking autoimmunity and airways disease. Chest. 2024 (In Press).
  28. Ford JA, Cho MH, Sparks JA. Bi-directional association of RA and COPD: Linking arthritis, inflammation, smoking, airways disease, and emphysema. Rheumatology. 2024 (In Press).
  29. Chang MH, Fuhlbrigge RC, Nigrovic PA. Joint-specific memory, resident memory T cells, and the rolling window of opportunity in arthritis. Nat Rev Rheumatol. 2024 (In Press).
  30. Bucci L, Hagen M, Rothe T, Raimondo MG, Fagni F, Tur C, Wirsching A, Wacker J, Wilhelm A, Auger JP, Pachowsky M, Eckstein M, Alivernini S, Zoli A, Krönke G, Uderhardt S, Bozec A, D’Agostino MA, Schett G, Grieshaber-Bouyer R. Bispecific T cell engager therapy for refractory rheumatoid arthritis. Nature Medicine 2024 https://doi.org/10.1038/s41591-024-02964-1
  31. Robinette, M. L., Weeks, L. D., Kramer, R. J., Agrawal, M., Gibson, C. J., Yu, Z., Sekar, A., Mehta, A., Niroula, A., Brown, J. T., McDermott, G. C., Reshef, E. R., Lu, J. E., Liou, V. D., Chiou, C. A., Natarajan, P., Freitag, S. K., Rao, D. A., & Ebert, B. L. Association of Somatic TET2 Mutations With Giant Cell Arteritis. Arthritis Rheumatol. 2024;76(3):438-443. https://doi.org/10.1002/art.42738
  32. Keijzer S, Oskam N, Ooijevaar-de Heer P, Steenhuis M, Keijser JBD, Wieske L, van Dam KPJ, Stalman EW, Kummer LYL, Boekel L, Kuijpers TW, Ten Brinke A, van Ham SM, Eftimov F, Tas SW, Wolbink GJ, Rispens T. Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection. Front Immunol. 2024 Feb 29;15:1314507. doi: 10.3389/fimmu.2024.1314507. PMID: 38487524; PMCID: PMC10937420.
  33. Valk AM, Keijser JBD, van Dam KPJ, Stalman EW, Wieske L, Steenhuis M, Kummer LYL, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Horváth B, Hijnen DJ, Schreurs CRG, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, Boekel L, Wolbink GJ, Keijzer S, Derksen NIL, van Deelen M, van Mierlo G, Kuijpers TW, Eftimov F, van Ham SM, Ten Brinke A, Rispens T; T2B! Immunity against SARS-CoV-2 study group. Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination. Allergy. 2024 Mar 4. doi: 10.1111/all.16089. Epub ahead of print. PMID: 38439527.
  34. Nagy NA, Hafkamp FMJ, Sparrius R, Bas R, Lozano Vigario F, van Capel TMM, van Ree R, Geijtenbeek TBH, Slütter B, Tas SW, de Jong EC. Retinoic acid-loaded liposomes induce human mucosal CD103+ dendritic cells that inhibit Th17 cells and drive regulatory T-cell development in vitro. Eur J Immunol. 2024 Mar 2:e2350839. doi: 10.1002/eji.202350839. Epub ahead of print. PMID: 38430190.
  35. Schenning LCM, Ottevanger R, Quint KD, Tas SW. An ulcerating skin tumour in a patient with rheumatoid arthritis. Ann Rheum Dis. 2024 Feb 5:ard-2023-225436. doi: 10.1136/ard-2023-225436. Epub ahead of print. PMID: 38316532.
  36. Schuitema A, Anjie SI, van Eeghen AM, Tas SW, Löwenberg M. Symptomatic creatine phosphokinase elevation in a Crohn’s disease patient caused by upadacitinib. Clin Case Rep. 2024 Jan 19;12(1):e8227. doi: 10.1002/ccr3.8227. PMID: 38250091; PMCID: PMC10799215.
  37. Besten YR, Boekel L, Steenhuis M, Hooijberg F, Atiqi S, Leeuw M, Vogelzang EH, Keijser J, Keijzer S, Loeff FC, Gerritsen M, Tas SW, Nurmohamed MT, Rispens T, Wolbink G. Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology. RMD Open. 2024 Apr 19;10(2):e003933. doi: 10.1136/rmdopen-2023-003933. PMID: 38642927; PMCID: PMC11033664.
  38. Leite CBG, Ormsby RT, Mekhail J, Charles JF, Gortz S, Merkley G, Lattermann C. Culturing Osteochondral Explants Under Rotatory Shaking or After Removing Bone Marrow Elements Increase Explant Cellular Viability. AmJSports, (in press).
  39. Kvacskay P, Merkt W. CD19.CAR-T cells versus Obinutuzumab-Who will win the race on deep B cell depletion in systemic autoimmunity?. Rheumatology (Oxford). Published online March 9, 2024. doi:10.1093/rheumatology/keae144
  40. Verstegen NJM, Hagen RR, Kreher C, Kuijper LH, Dijssel JVD, Ashhurst T, Kummer LYL, Palomares Cabeza V, Steenhuis M, Duurland MC, Jongh R, Schoot CEV, Konijn VAL, Mul E, Kedzierska K, van Dam KPJ, Stalman EW, Boekel L, Wolbink G, Tas SW, Killestein J, Rispens T, Wieske L, Kuijpers TW, Eftimov F, van Kempen ZLE, van Ham SM, Ten Brinke A, van de Sandt CE; T2B! immunity against SARS-CoV-2 study group. T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination. J Neurol Neurosurg Psychiatry. 2024 Mar 28:jnnp-2023-332224. doi: 10.1136/jnnp-2023-332224. Epub ahead of print. PMID: 38548324.
  41. Besten YR, Boekel L, Steenhuis M, Hooijberg F, Atiqi S, Leeuw M, Vogelzang EH, Keijser J, Keijzer S, Loeff FC, Gerritsen M, Tas SW, Nurmohamed MT, Rispens T, Wolbink G. Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology. RMD Open. 2024 Apr 19;10(2):e003933. doi: 10.1136/rmdopen-2023-003933. PMID: 38642927; PMCID: PMC11033664.
  42. Singh N, Shahane A, Sparks JA, Bitoun S, Cappelli LC. Inflammatory arthritis due to immune checkpoint inhibitors: Current approaches to management. Rheum Dis Clin. 2024 May;50(2):269-79.
  43. Juge PA, Sparks JA, Gazal S, Borie R, Debray MP, Kannengiesser C, McDermott GC, Cui J, Hayashi K, Doyle T, van Moorsel CHM, Knevel R, Heckert Sl, Boxma-de Klerk BM, Vasarmidi E, Antoniou K, van der Helm AHM, Boileau C, Crestani B, Dieudé P. RPA3-UMAD1 rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestry. Rheumatol Adv Pract. 2024 (In Press).
  44. Chang MH, Fuhlbrigge RC, Nigrovic PA. Joint-specific memory, resident memory T cells, and the rolling window of opportunity in arthritis. Nat Rev Rheumatol. 2024 May;20(5):258-271.
  45. Elahee M, Mueller AA, Wang R, Marks KE, Sasaki T, Cao Y, Fava A, Dellaripa PF, Boin F, Rao DA. A PD-1highCD4+T Cell Population With a Cytotoxic Phenotype is Associated With Interstitial Lung Disease in Systemic Sclerosis. ACR Open Rheumatol. 2024 May 3. doi: 10.1002/acr2.11671. Epub ahead of print. PMID: 38698736.
  46. Jain A, Hakim S, Woolf CJ. Immune drivers of physiological and pathological pain. J Exp Med. 2024;221(5):e20221687. doi:10.1084/jem.20221687
  47. Merkt W, Lorenz HM, Schmitt M. CAR T-Cell Therapy in Autoimmune Disease. N Engl J Med. 2024;390(17):1628-1629. doi:10.1056/NEJMc2403705
  48. Röhrich, M., Rosales, J. J., Hoppner, J., Kvacskay, P., Blank, N., Loi, L., Paech, D., Schreckenberger, M., Giesel, F., Kauczor, H. U., Lorenz, H. M., Haberkorn, U., & Merkt, W. Fibroblast Activation Protein Inhibitor-Positron Emission Tomography in Aortitis: Fibroblast pathology in active inflammation and remission. Rheumatology (Oxford). Published online April 22, 2024. doi:10.1093/rheumatology/keae225
  49. Stalman EW, Wieske L, Keijser JBD, van Dam KPJ, Kummer LYL, Wilbrink MF, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, Boekel L, Wolbink GJ, van der Kooi AJ, Raaphorst J, Löwenberg M, Takkenberg RB, D’Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl AE, Broens B, Sanchez AP, van Els CACM, de Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart RCF, Teng YKO, van Paassen P, Busch MH, Brusse E, van Doorn PA, Baars AE, Hijnen D, Schreurs CRG, van der Pol WL, Goedee HS, Steenhuis M, Keijzer S, Cristianawati O, Brinke AT, Verstegen NJM, Zwinderman KAH, van Ham SM, Rispens T, Welkers MR, Jonges M, Eftimov F, Kuijpers TW; T2B! immunity against SARS-CoV-2 study group. Clinical and humoral responses after SARS-CoV-2 breakthrough infections in patients with immunosuppressants. J Allergy Clin Immunol. 2024 May 17:S0091-6749(24)00503-7. doi: 10.1016/j.jaci.2024.04.031. Epub ahead of print. PMID: 38763170.
  50. Curtis JR, Wollenhaupt J, Tas SW, Chatzidionysiou K, Wang L, Roberts K, Tsekouras V. Determinants of tofacitinib discontinuation in adult patients with rheumatoid arthritis during long-term extension studies up to 9.5 years. Rheumatol Adv Pract. in press.
  51. Sparks JA, Dieudé P, Hoffmann-Vold AM, Burmester GR, Walsh SLF, Kreuter M, Stock C, Sambevski S, Alves M, Emery P. Design of ANCHOR RA: A multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis: ANCHOR-RA. BMC Rheumatol. 2024 May 21;8(1):19.
  52. Joerns EK, Karp D, Sparks JA, Adams TN, Makris UE, Newton CA. High interleukin-13 level is associated with disease stability in interstitial lung disease. Heliyon. 2024 (In Press).
  53. CAR T-cell therapy in rheumatology-What we know so far? Hagen M, Wirsching A, Bohr D, Taubmann J, Müller F, Mackensen A, Grieshaber-Bouyer R*, Schett G* Z Rheumatol. 2024 May 23. doi: 10.1007/s00393-024-01514-x
  54. Selective CAR-T cell mediated B cell depletion suppresses interferon signature in SLE. Wilhelm A, Chambers D, Müller F, Bozec A, Grieshaber-Bouyer R, Winkler T, Mougiakakos D, Mackensen A, Schett G, Krönke G JCI Insight. 2024 May 9:e179433. doi: 10.1172/jci.insight.179433
  55. Dunlap, G., Wagner, A., Meednu, N., Zhang, F., Jonsson, A. H., Wei, K., Sakaue, S., Nathan, A., Accelerating Medicines Partnership Program: Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Network, Bykerk, V. P., Donlin, L. T., Goodman, S. M., Firestein, G. S., Boyle, D. L., Holers, V. M., Moreland, L. W., Tabechian, D., Pitzalis, C., Filer, A., Raychaudhuri, S., Brenner, M., McDavid, A., Rao, D., Anolik, J. H. (2023). Clonal associations between lymphocyte subsets and functional states in rheumatoid arthritis synovium. Nat Commun 15, 4991 (2024). https://doi.org/10.1038/s41467-024-49186-0
  56. Kratchmarov R, Djeddi S, Dunlap G, He W, Jia X, Burk CM, Ryan T, McGill A, Allegretti JR, Kataru RP, Mehrara BJ, Taylor EM, Agarwal S, Bhattacharyya N, Bergmark RW, Maxfield AZ, Lee S, Roditi R, Dwyer DF, Boyce JA, Buchheit KM, Laidlaw TM, Shreffler WG, Rao DA, Gutierrez-Arcelus M, Brennan PJ. TCF1-LEF1 co-expression identifies a multipotent progenitor cell (TH2-MPP) across human allergic diseases. Nat Immunol. 2024 May;25(5):902-915. doi: 10.1038/s41590-024-01803-2. Epub 2024 Apr 8.
  57. Wang Q*, Kim T*, Martínez-Bonet M, Sim S, Aguiar V, Cui J, Sparks JA, Chen X, Todd M, Wauford B, Marion MC, Langefeld CD, Weirauch MT, Gutierrez-Arcelus M, Nigrovic PA. High-throughput identification of functional regulatory SNPs in systemic lupus erythematosus. Nature Comm 2024 in press
  58. Hayward K, Grom A, Muscal E, Nigrovic PA, Rouster-Stevens KA, Ardalan K, Hiraki L, Moorthy LN. Longitudinal program evaluation of an inter-institutional mentorship network for pediatric rheumatology using a quality improvement framework. Pediatric Rheum 2024 in press.

2023

  1. Kronzer VL, Hayashi K, Yoshida K, McDermott GC, Davis JM III, Huang W, Dellaripa PF, Cui J, Feathers V, Gill RR, Hatabu H, Nishino M, Blaustein R, Crowson CS, Robinson WH, Sokolove J, Liao KP, Weinblatt ME, Shadick NA, Doyle TJ+, Sparks JA+. Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: A nested case-control study. Lancet Rheumatol. 2023;5(2):e77-87. (+co-senior author)
  2. Qian G, Wang X, Patel NJ, Kawano Y, Fu X, Cook CE, Vanni KMM, Kowalski EN, Banasiak EP, Bade K, Srivatsan S, Williams Z, Todd DJ, Weinblatt ME, Wallace ZS+, Sparks JA+. Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study. Lancet Rheumatol. 2023;5(3):e139-50. (+co-senior author)
  3. Whelan MG, Santacroce L, Masto L, Qian G, Kowalski E, Vanni K, Weinblatt ME, Sparks JA, Tedeschi SK. Predictors of low spike antibody response in persons with systemic rheumatic disease after an initial course of COVID-19 vaccination. Clin Rheumatol. 2023 Jan 19;1-6. doi: 10.1007/s10067-023-06512-z.
  4. Lee H, Sparks JA, Lee SB, Yoshida K, Desai RJ, Landon JE, Kim SC. Validation of serostatus of rheumatoid arthritis using ICD-10 codes in administrative claims data. Pharmacoepidemiol Drug Saf. 2023 Feb 2. doi: 10.1002/pds.5597.
  5. McCarter KR, Wolfgang T, Arabelovic S, Wang X, Yoshida K, Banasiak EP, Qian G, Kowalski EN, Vanni KMM, LeBoeuf NR, Buchbinder EI, Gedmintas L, MacFarlane LA, Rao DA, Shadick NA, Gravallese EM, Sparks JA. Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: A retrospective, comparative, cohort study. Lancet Rheumatol. 2023 May;5(5):e274-e283.
  6. Wei J, Zhang W, Doherty M, Wallace ZS, Sparks JA, Lu N, Li X, Zeng Z, Lei G, Zhang Y. Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19. BMC Med. 2023;21(1):78.
  7. Jiang X, Sparks JA, Wallace ZS, Deng X, Li H, Lu N, Xie D, Wang Y, Zeng C, Lei G, Wei J, Zhang Y. Risk of COVID-19 among unvaccinated and vaccinated patients with systematic lupus erythematosus: A general population study. RMD Open. 2023;9(1):e002839.
  8. Bass AR, Wahab NA, Reid P, Sparks JA, Calabrese C, Jannat-Khah D, Ghosh N, Rajesh D, Aude N, Gedmintas L, MacFarlane L, Arabelovic S, Falohun A, Mushtak K, Al Haj F, Diab A, Shah AA, Bingham CO III, Chan KK, Cappelli LC. Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis. Ann Rheum Dis. 2023 Jul;82(7):920-926.
  9. Zaccardelli A, Wallace ZS, Sparks JA. Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: Lessons learned and emerging directions 3 years into the pandemic. Curr Opin Rheumatol. Curr Opin Rheumatol. 2023 May 1;35(3):175-184. doi: 10.1097/BOR.0000000000000930.
  10. Volkmann ER, Sparks JA, Hoffman-Vold AM, Doyle TJ, Emery P, Dieudé P. Preclinical or subclinical rheumatoid arthritis-related interstitial lung disease: Misleading terms with potentially deleterious consequences. Lancet Rheumatol. 2023 Mar;5(3):e116-e118.
  11. Talarico R, Ramirez GA, Barreira SC, Cardamone C, Triggianese P, Aguilera S, Andersen J, Avcin T, Benistan K, Bertsias G, Bortoluzzi A, Bouillot C, Bulina I, Burmester GR, Callens S, Carreira PE, Cervera R, Cutolo M, Damian L, Della-Torre E, Faria R, Fonseca JE, Galetti I, Hachulla E, Iaccarino L, Jacobsen S, Khmelinskii N, Limper M, Marinello D, Meyer A, Moroncini G, Nagy G, Olesinska M, Pamfil C, Pileckyte M, Pistello M, Rednic S, Richez C, Romão VC, Schneider M, Sciascia S, Scirè CA, Simonini G, Smith V, Sulli A, Tani C, Tas SW, Tincani A, Vonk MC, Tektonidou M, Mosca M. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products. Clin Exp Rheumatol. 2023 Mar;41(3):543-553. doi: 10.55563/clinexprheumatol/jpargp.  PMID: 36916322
  12. Mol S, Taanman-Kueter EWM, van der Steen BA, Groot Kormelink T, van de Sande MGH, Tas SW, Wauben MHM, de Jong EC. Hyaluronic Acid in Synovial Fluid Prevents Neutrophil Activation in Spondyloarthritis. Int J Mol Sci. 2023 Feb 4;24(4):3066. doi: 10.3390/ijms24043066. PMID: 36834478 Free PMC article.
  13. Gosselt HR, van Lint JA, Kosse LJ, Spuls PI, Vonkeman HE, Tas SW, Hoentjen F, Nurmohamed MT, van den Bemt BJF, van Doorn MBA, Jessurun NT. Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases. Expert Opin Drug Saf. 2023 Mar 1:1-7. doi: 10.1080/14740338.2023.2181340.  PMID: 36794307
  14. Wieske L, Stalman EW, van Dam PJK, Kummer LY, Steenhuis M, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, Boekel L, Wolbink G, Van der Kooi A, Raaphorst J, Löwenberg M, Takkenberg B, D’Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl A, Broens B, Parra Sanchez A, van Els CACM, Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart CF, Teng YKO, van Paassen P, Busch MH, Jallah PBP, Brusse E, van Doorn PA, Baars AE, Hijnen D, Schreurs CRG, Van der Pol WL, Goedee HS, Keijzer S, Keijser J, Cristianawati O, Ten Brinke A, Verstegen NJM, Zwinderman KAH, van Ham SM, Kuijpers TW, Rispens T, Eftimov F; T2B! immunity against SARS-CoV-2 study group. Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases. Ann Rheum Dis. 2023 Jan 31:ard-2022-223464. doi: 10.1136/ard-2022-223464.  PMID: 36720583 No abstract available.
  15. Kaaij MH, van Hamburg JP, van Rooijen CCN, Grüneboom A, Kan YY, Pots D, Schett G, van Ruijven LJ, van Duivenvoorde LM, Huitema LFA, Baeten DLP, Tas SW. Increased Type H Blood Vessels Precedes Pathological Osteogenesis And Inflammation In Experimental Spondyloarthritis. Arthritis Rheumatol. 2023 Jan 19. doi: 10.1002/art.42449. PMID: 36657110
  16. van Dam KPJ, Wieske L, Stalman EW, Kummer LYL, Roosen J, van Kempen ZLE, Killestein J, Volkers AG, Boekel L, Wolbink GJ, van der Kooi AJ, Raaphorst J, Löwenberg M, Takkenberg RB, D’Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl AE, Broens B, Sanchez AP, van Els CACM, de Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart RCF, Teng YKO, van Paassen P, Busch MH, Jallah PBP, Brusse E, van Doorn PA, Baars AE, Hijnen DJ, Schreurs CRG, van der Pol WL, Goedee HS, Steenhuis M, Keijzer S, Keijser JBD, Cristianawati O, Rispens T, Brinke AT, Verstegen NJM, Marieke van Ham S, Tas SW, Kuijpers TW, Eftimov F; T2B! Immunity against SARS-CoV-2 study group. Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations. J Autoimmun. 2023 Feb;135:102984. doi: 10.1016/j.jaut.2022.102984.PMID: 36621174 Free PMC article.
  17. van der Weele L, Niessink T, Maas M, Don Griot P, Janssen M, Otto C, Jansen TL, Tas SW, de Vries N. Clinical image: synovitis of the metacarpophalangeal joints. Ann Rheum Dis. 2022 Nov 14:ard-2022-223290. doi: 10.1136/ard-2022-223290. PMID: 36376027 No abstract available.
  18. Stalman EW, Wieske L, van Dam KPJ, Kummer LY, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, Boekel L, Wolbink GJ, Van der Kooi AJ, Raaphorst J, Löwenberg M, Takkenberg RB, D’Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl AE, Broens B, Parra Sanchez A, van Els CACM, Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart CF, Teng OYK, van Paassen P, Busch MH, Jallah PBP, Brusse E, van Doorn PA, Baars AE, Hijnen DJ, Schreurs CRG, Van der Pol WL, Goedee HS, Steenhuis M, Keijzer S, Keijser JBD, Boogaard A, Cristianawati O, Ten Brinke A, Verstegen NJM, Zwinderman KAH, Rispens T, van Ham SM, Kuijpers TW, Eftimov F; T2B! immunity against SARS-CoV-2 study group. Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases.Ann Rheum Dis. 2022 Dec;81(12):1757-1766. doi: 10.1136/ard-2022-222904. PMID: 36357161
  19. Merino-Vico A, Frazzei G, van Hamburg JP, Tas SW. Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches. Eur J Immunol. 2023 Jan;53(1):e2149675. doi: 10.1002/eji.202149675. PMID: 36314264 Review.
  20. Frazzei G, Musters A, de Vries N, Tas SW, van Vollenhoven RF. Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals.Autoimmun Rev. 2023 Jan;22(1):103217. doi: 10.1016/j.autrev.2022.103217.  PMID: 36280095 Free article. Review.
  21. Roest LH, Kosse LJ, van Lint JA, Gosselt HR, Scholl JHG, van Puijenbroek E, Vonkeman HE, Tas SW, Nurmohamed MT, van den Bemt BJF, Jessurun NT. Disease-specific ADRs of TNF-α inhibitors as reported by patients with inflammatory rheumatic diseases: a registry-based prospective multicenter cohort study.Expert Opin Drug Saf. 2022 Aug 28:1-9. doi: 10.1080/14740338.2022.2115479.  PMID: 36036179
  22. Mangini M, D’Angelo R, Vinciguerra C, Payré C, Lambeau G, Balestrieri B, Charles JF, Mariggiò S. Multimodal regulation of the osteoclastogenesis process by secreted group IIA phospholipase A2. Front Cell Dev Biol. 2022;10:966950. doi: 10.3389/fcell.2022.966950. eCollection 2022. PMC9467450.
  23. Zhang C, Vedadghavami A, He T, Charles JF and Bajpayee AG. Cationic Carrier Mediated Delivery of Anionic Contrast Agents in Low Doses Enable Enhanced Computed Tomography Imaging of Cartilage for Early Osteoarthritis Diagnosis. ACS Nano 2023. March 29. doi: 10.1021/acsnano.2c12376.
  24. 2023 ORS Oral Abstract: Leite CBG, Tavares LP, Mekhail J, Merkely G, Whalen J, Charles JF, Lattermann C. Transection of the anterior cruciate ligament leads to a physiological production of specialized pro-resolving mediators that does not prevent posttraumatic osteoarthritis.
  25. Wobma H, Arvila S R, Taylor ML, Lam K, Ohashi M, Gebhart C, Powers H, Case S M, Chandler M, Chang MH, Cohen E M, Day-Lewis M, Fishman M P, Halyabar O, Hausmann J S, Hazen M M, Lee PY, Lo M, Meidan E, Roberts J E, Son MB, Sundel RP, Dedeoglu F, Nigrovic PA, Casey A, Chang JC, Henderson LA. Incidence and risk factors for eosinophilia and lung disease in biologic-exposed children with systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2023 Oct;75(10):2063-2072.
  26. Du Y, Liu M, Nigrovic PA, Dedeoglu F, Lee PY. Biologics and JAK inhibitors for the treatment of monogenic systemic autoinflammatory diseases in children. J All Clin Immunol 2023;151:607-618. PMID: 36707349.
  27. Belizaire, R., Wong, W.J., Robinette, M.L. et al. Clonal haematopoiesis and dysregulation of the immune system. Nat Rev Immunol (2023). https://doi.org/10.1038/s41577-023-00843-3
  28. Holly Wobma, MD PhD, Malika Kapadia, MD, Haesook T. Kim, PhD, Francesca Alvarez Calderon, MD PhD, Susanne Baumeister, MD, Christine Duncan, MD, Suzanne Forrest, MD,Lev Gorfinkel, MD, Jennifer Huang, MD, Leslie E. Lehmann, MD, Hojun Li, MD PhD, Marc Schwartz, MD PhD, John Koreth, MBBS DPhil, Jerome Ritz, MD, Leslie S. Kean, MD PhD, Jennifer S. Whangbo, MD PhD Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease. Blood Adv. 2023 May 24:bloodadvances.2023009729. doi: 10.1182/bloodadvances.2023009729.
  29. Fa’ak F, Buni M, Falohun A, Lu H, Song J, Johnson D, Zobniw CM, Trinh VA, Awiwi MO, Elsayes KM, Ludford K, Dimitrova M, Sandigursky S, Cunningham-Bussel A, Sparks JA, Abu-Shawer O, Rahma OE, Thanarajasingam U, Zeman AM, Talukder R, Singh N, Chung SH, Grivas P, Daher M, Abudayyeh A, Weber JS, Tayar J, Diab A, Suarez-Almazor M, Abdel-Wahab N, Diab A. Selective immune suppression using interleukin-6 inhibitors for management of immune-related adverse events. J Immunother Cancer. 2023 Jun;11(6):e006814.
  30. Zheni Stavre , Jung-Min Kim, Yeon-Suk Yang, Kerstin Nündel , Sachin Chaugule , Tadatoshi Sato, Kwang Hwan Park, Guangping Gao, Ellen M. Gravallese, and Jae-Hyuck Shim. Schnurri-3 inhibition suppresses bone and joint damage in models of rheumatoid arthritis. Proc Natl Acad Sci U S A. 2023 May 9;120(19):e2218019120.
  31. Susan MacLauchlan, Priyanka Kushwaha, Albert Tai, Jia Chen, Catherine Manning, Gaurav Swarnkar, Yousef Abu-Amer, Katherine A. Fitzgerald, Shruti Sharma, and Ellen M. Gravallese. STING-dependent interferon signatures restrict osteoclast differentiation and bone loss in mice. PNAS. 2023; 11:120(15):e2210409120. PMID: 37023130. PMC10104545.
  32. Takeoka Y, Kanda Y, Kang JD, Mizuno S. Regenerative Capability of Human Nucleus Pulposus Cells in Degenerated Disc Under Hydrostatic Pressure Mimicking Physiologically Relevant Intradiscal Pressure In Vitro. Spine (Phila Pa 1976). 2023 May 15;48(10):728-736. doi: 10.1097/BRS.0000000000004530.  PMID: 36856558. PMC10118243.
  33. van Dam KPJ, Volkers AG, Wieske L, Stalman EW, Kummer LYL, van Kempen ZLE, Killestein J, Tas SW, Boekel L, Wolbink GJ, van der Kooi AJ, Raaphorst J, Takkenberg RB, D’Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl AE, Broens B, Sanchez AP, van Els CACM, de Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart RCF, Teng YKO, van Paassen P, Busch MH, Jallah PBP, Brusse E, van Doorn PA, Baars AE, Hijnen DJ, Schreurs CRG, van der Pol WL, Goedee HS, Steenhuis M, Keijzer S, Keijser JBD, Cristianawati O, Ten Brinke A, Verstegen NJM, van Ham SM, Rispens T, Kuijpers TW, Löwenberg M, Eftimov F; T2B! Immunity against SARS-CoV-2 study group. Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity. BMC Infect Dis. 2023 May 17;23(1):332.
  34. Bergkamp SC, Wahadat MJ, Salah A, Kuijpers TW, Smith V, Tas SW, van den Berg JM, Kamphuis S, Schonenberg-Meinema D. Dysregulated endothelial cell markers in systemic lupus erythematosus: a systematic review and meta-analysis. J Inflamm (Lond). 2023 May 16;20(1):18.
  35. van Lint JA, Jessurun NT, Tas SW, Vonkeman HE, van Doorn MBA, Hoentjen F, Nurmohamed MT, van Puijenbroek EP, van den Bemt BJF. Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor. BioDrugs. 2023 Apr 3. doi: 10.1007/s40259-023-00592-8.
  36. McDermott GC, Hayashi K, Yoshida K, Moll M, Cho MH, Doyle TJ, Kinney G, Dellaripa PF, Putman RK, San Jose Estepar R, Hata A, Hino T, Hida T, Yanagawa M, Nishino M, Washko G, Regan E, Hatabu H, Hunninghake GM, Silverman EK, Sparks JA. Prevalence and mortality associations of interstitial lung abnormalities in rheumatoid arthritis within a multicenter prospective cohort of smokers. Rheumatology (Oxford). 2023 Oct 23;62(SI3):SI286-SI295.
  37. Venkat R, Wallace ZS, Sparks JA. Considerations for pharmacologic management of rheumatoid arthritis in the COVID-19 era: A narrative review. Curr Rheumatol Rep. 2023 Nov;25(11):236-245.
  38. Virgen CA, Tawa M, Sparks JA, Nohria A, O’Hare MJ, LaBoeuf NR, Kupper TS, Fisher DC, Larocca C. Mogamulizumab-associated myositis in patients with T-cell lymphoma. Oncologist. 2023 Aug 3;28(8):e694-e698. doi: 10.1093/oncolo/oyad155.
  39. Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, McCorkell L, Nadkarni GN, Parthasarathy S, Singh U, Walker TA, Selvaggi CA, Shinnick DJ, Schulte CCM, Atchley-Challenner R, Horwitz LI, Foulkes AS; RECOVER Consortium Authors for the RECOVER Consortium; Alba GA, Alicic R, Altman N, Anglin K, Argueta U, Ashktorab H, Baslet G, Bassett IV, Bateman L, Bedi B, Bhattacharyya S, Bind MA, Blomkalns AL, Bonilla H, Bush PA, Castro M, Chan J, Charney AW, Chen P, Chibnik LB, Chu HY, Clifton RG, Costantine MM, Cribbs SK, Davila Nieves SI, Deeks SG, Duven A, Emery IF, Erdmann N, Erlandson KM, Ernst KC, Farah-Abraham R, Farner CE, Feuerriegel EM, Fleurimont J, Fonseca V, Franko N, Gainer V, Gander JC, Gardner EM, Geng LN, Gibson KS, Go M, Goldman JD, Grebe H, Greenway FL, Habli M, Hafner J, Han JE, Hanson KA, Heath J, Hernandez C, Hess R, Hodder SL, Hoffman MK, Hoover SE, Huang B, Hughes BL, Jagannathan P, John J, Jordan MR, Katz SD, Kaufman ES, Kelly JD, Kelly SW, Kemp MM, Kirwan JP, Klein JD, Knox KS, Krishnan JA, Kumar A, Laiyemo AO, Lambert AA, Lanca M, Lee-Iannotti JK, Logarbo BP, Longo MT, Luciano CA, Lutrick K, Maley JH, Marathe JG, Marconi V, Marshall GD, Martin CF, Matusov Y, Mehari A, Mendez-Figueroa H, Mermelstein R, Metz TD, Morse R, Mosier J, Mouchati C, Mullington J, Murphy SN, Neuman RB, Nikolich JZ, Ofotokun I, Ojemakinde E, Palatnik A, Palomares K, Parimon T, Parry S, Patterson JE, Patterson TF, Patzer RE, Peluso MJ, Pemu P, Pettker CM, Plunkett BA, Pogreba-Brown K, Poppas A, Quigley JG, Reddy U, Reece R, Reeder H, Reeves WB, Reiman EM, Rischard F, Rosand J, Rouse DJ, Ruff A, Saade G, Sandoval GJ, Schlater SM, Shepherd F, Sherif ZA, Simhan H, Singer NG, Skupski DW, Sowles A, Sparks JA, Sukhera FI, Taylor BS, Teunis L, Thomas RJ, Thorp JM, Thuluvath P, Ticotsky A, Tita AT, Tuttle KR, Urdaneta AE, Valdivieso D, VanWagoner TM, Vasey A, Verduzco-Gutierrez M, Wallace ZS, Ward HD, Warren DE, Weiner SJ, Welch S, Whiteheart SW, Wiley Z, Wisnivesky JP, Yee LM, Zisis S. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023 May 25. doi: 10.1001/jama.2023.8823. PMID: 37278994. PMC10214179 
  40. Herman JD, Atyeo C, Zur Y, Cook CE, Patel NJ, Vanni KMM, Kowalski EN, Qian G, Srivatsan S, Shadick NA, Rao DA, Kellman B, Mann CJ, Laffenburger D, Wallace ZS*, Sparks JA*, Alter G*. Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases. Sci Transl Med. 2023 Sep 6;15(712):eadf6598. *Contributed equally.
  41. Good SD, Sparks JA, Volkmann ER. Screening, diagnosis, and monitoring of interstitial lung disease in systemic autoimmune rheumatic diseases: A narrative review. Rev Colomb Reumatol. 2023.
  42. Wang R, Singaraju A, Marks K, Shakib L, Dunlap G, Cunningham-Bussel A, Chen L, Tirpack A, Fein MR, Todd DJ, MacFarlane L, Goodman SM, DiCarlo EF, Massarotti EM, Sparks JA, Hamnvik OR, Min L, Jonsson AH, Brenner MB, Chan K, Bass AR, Donlin LT, Rao DA. Clonally expanded CD38hi cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor-associated arthritis. Sci Immunol. 2023 Jul 28;8(85):eadd1591.
  43. Moll M, Peljto AL, Kim JS, Xu H, Debban C, Chen X, Menon A, Putman R, Ghosh AJ, Nishino M, Hatabu H, Hobbs BD, Wain LV, Allen RJ, Tobin MD, Taby AB, Chun S, McDermott GC, Sparks JA, Silverman EK, Ortega V, Garcia CK, Barr RG, Manichaikul A, Dupuis J, Fingerlin TE, Hunninghake GM, Schwartz DA, Cho MH. A polygenic risk score for idiopathic pulmonary fibrosis and interstitial lung abnormalities. Am J Respir Crit Care Med. 2023 Oct 1;208(7):791-801.
  44. Philippon EM, van Rooijen LJ, Khodadust F, van Hamburg JP, van der Laken CJ, Tas SW. A novel 3D Spheroid Model of Rheumatoid Arthritis Synovial Tissue Incorporating Fibroblasts, Endothelial Cells, and Macrophages. Front Immunol. 2023. Doi: 10.3389/fimmu.2023.1188835.
  45. Boekel L, Atiqi S, Leeuw M, Hooijberg F, Besten YR, Wartena R, Steenhuis M, Vogelzang E, Webers C, Boonen A, Gerritsen M, Lems WF, Tas SW, van Vollenhoven RF, Voskuyl AE, van der Horst-Bruinsma I, Nurmohamed M, Rispens T, Wolbink G. Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands. Lancet Rheumatol. 2023 Jul;5(7):e375-e385. doi: 10.1016/S2665-9913(23)00127-3.  PMID: 37398978. PMC10292827.
  46. Nagy NA, Lozano Vigario F, Sparrius R, van Capel TMM, van Ree R, Tas SW, de Vries IJM, Geijtenbeek TBH, Slütter B, de Jong EC; DC4Balance consortium. Liposomes loaded with vitamin D3 induce regulatory circuits in human dendritic cells. Front Immunol. 2023 Jun 9;14:1137538. doi: 10.3389/fimmu.2023.1137538. PMID: 37359530. PMC10288978.
  47. Wobma H, Arvila S, Taylor M, Lam KP, Ohashi M, Gebhart C, Powers H, Case S, Chandler M, Chang MH, Cohen E, Day-Lewis M, Fishman M, Halyabar O, Hausmann J, Hazen M, Lee PY, Lo M, Meidan E, Roberts J, Son MBF, Sundel RP, Dedeoglu F, Nigrovic PA, Casey A, Chang JC, Henderson LA. Incidence and risk factors for eosinophilia and lung disease in biologic-exposed children with systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2023 Oct;75(10):2063-2072. doi: 10.1002/acr.25129.
  48. Van Bruggen A, Jarrot PA, Thomas E, Sheehy CE, Silva CMS, Hsu AY, Cunin P, Nigrovic PA, Gomes E, Luo HR, Waterman C, Wagner DD. NLRP3 is essential for neutrophil polarization and chemotaxis in response to leukotriene B4 gradient. Proc Natl Acad Sci U S A. 2023 Aug 29;120(35):e2303814120.
  49. Nigrovic PA, de Benedetti F, Kimura Y, Lovell DJ, Vastert SJ. The elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset Still’s disease. Pediatr Rheumatol Online J. 2024 Jan 5;21(Suppl 1):114.
  50. Zhang C, Vedadghavami A, He T, Charles JF, Bajpayee AG. Cationic Carrier Mediated Delivery of Anionic Contrast Agents in Low Doses Enable Enhanced Computed Tomography Imaging of Cartilage for Early Osteoarthritis Diagnosis. ACS Nano. 2023 Apr 11;17(7):6649-6663. doi: 10.1021/acsnano.2c12376. PubMed PMID: 36989423.
  51. Sparks JA, Harrold LR, Simon TA, Wittstock K, Kelly S, Lozenski K, Khaychuk V, Michaud K. Comparative effectiveness of treatments for rheumatoid arthritis in clinical practice: A systematic review. Semin Arthritis Rheum. 2023 Oct:62:152249.
  52. Kronzer VL, Hayashi K, Crowson CS, Davis JM III, McDermott GC, Cui J, Losina E, Juge PA, Cerhan JR, Sparks JA. Gene-respiratory disease interactions for rheumatoid arthritis risk. Semin Arthritis Rheum. 2023 Dec:63:152254.
  53. Lutter L, Ter Linde JJM, Brand EC, Hoytema van Konijnenburg DP, Roosenboom B, Talabur-Horje CH, Oldenburg B, van Wijk F. Compartment-driven imprinting of intestinal CD4 T cells in inflammatory bowel disease and homeostasis. Clin Exp Immunol. 2023 Dec 13;214(3):235-248. doi: 10.1093/cei/uxad095.  PMID: 3756562
  54. Nguyen AA, Habiballah SB, LaBere B, Day-Lewis M, Elkins M, Al-Musa A, Chu A, Jones J, Fried AJ, McDonald D, Hoytema van Konijnenburg DP, Rockowitz S, Sliz P, Oettgen HC, Schneider LC, MacGinnitie A, Bartnikas LM, Platt CD, Ohsumi TK, Chou J. Rethinking immunologic risk: a retrospective cohort study of severe SARS-CoV-2 infections in individuals with congenital immunodeficiencies. J Allergy Clin Immunol Pract. 2023 Aug 4:S2213-2198(23)00815-2. doi: 10.1016/j.jaip.2023.07.042. PMID: 37544429
  55. Van Bruggen A, Jarrot PA, Thomas E, Sheehy CE, Silva CMS, Hsu AY, Cunin P, Nigrovic PA, Gomes E, Luo HR, Waterman C, Wagner DD. NLRP3 is essential for neutrophil polarization and chemotaxis in response to leukotriene B4 gradient. Proc Nat Acad Sci 2023 Aug 29;120(35):e2303814120. PMID: 37603754
  56. Leite CBG, Merkely G, Charles JF*, Lattermann C*. From Inflammation to Resolution: Specialized Pro-resolving Mediators in Posttraumatic Osteoarthritis. Curr Osteoporos Rep. 2023 Aug 24. doi: 10.1007/s11914-023-00817-3. PubMed PMID: 37615856.*co-senior authors.
  57. Leavis HL, van Daele PLA, Mulders-Manders C, Michels R, Rutgers A, Legger E, Bijl M, Hak EA, Lam-Tse WK, Bonte-Mineur F, Fretter P, Simon A, van Paassen P, van der Goes M, Flendrie M, Vercoutere W, van Lieshout AWT, Leek A, Vastert SJ, Tas SW. Management of adult-onset Still’s disease: evidence- and consensus-based recommendations by experts. Rheumatology (Oxford). 2023 Sep 5:kead461. doi: 10.1093/rheumatology/kead461. PubMed PMID: 37669122.
  58. Theeuwes WF, Di Ceglie I, Dorst DN, Blom AB, Bos DL, Vogl T, Tas SW, Jimenez-Royo P, Bergstrom M, Cleveland M, van der Kraan PM, Laverman P, Koenders MI, van Lent PL, van den Bosch MHJ. CD64 as novel molecular imaging marker for the characterization of synovitis in rheumatoid arthritis. Arthritis Res Ther. 2023 Aug 31;25(1):158. doi: 10.1186/s13075-023-03147-y. PubMed PMID: 37653557. PMC10468866.
  59. Moll M, Sordillo JE, Ghosh AJ, Hayden LP, McDermott G, McGeachie MJ, Dahlin A, Tiwari A, Manmadkar MG, Abston ED, Pavuluri C, Saferali A, Begum S, Ziniti JP, Gulsvik A, Bakke PS, Aschard H, Iribarren C, Hersh CP, Sparks JA, Hobbs BD, Lasky-Su JA, Silverman EK, Weiss ST, Wu AC, Cho MH. Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2023 Aug 16:S0091-6749(23)00988-0. doi: 10.1016/j.jaci.2023.08.002. Pubmed PMID: 37595761
  60. Yazdany J, Ware A, Wallace ZS, Bhana S, Grainger R, Hachulla E, Richez C, Cacoub P, Hausmann JS, Liew JW, Sirotich E, Jacobsohn L, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Ribeiro SLE, Al-Emadi S, Hasseli R, Müller-Ladner U, Specker C, Schulze-Koops H, Bernardes M, Machado Fraga V, Rodrigues AM, Sparks JA, Ljung L, Di Giuseppe D, Tidblad L, Wise L, Duarte-García A, Ugarte-Gil MF, Colunga-Pedraza IJ, Martínez-Martínez MU, Alpizar-Rodriguez D, Xavier RM, Isnardi CA, Pera M, Pons-Estel G, Izadi Z, Gianfrancesco MA, Carrara G, Scirè CA, Zanetti A, Machado PM. Impact of risk factors on COVID-19 outcomes in unvaccinated people with rheumatic diseases. Arthritis Care Res. 2023 Aug 29. doi: 10.1002/acr.25220. PubMed PMID: 37643903
  61. Joerns EK, Sparks JA. Interstitial pneumonia with autoimmune features: Aiming to define, refine, and treat. Rev Colomb Reumatol. 2023.
  62. Hackert NS*, Radtke FA*, Exner T*, Lorenz HM, Mueller-Tidow C, Nigrovic PA, Wabnitz G, Grieshaber-Bouyer R. Human and murine neutrophils share core transcriptional programs in both homeostatic and inflamed contexts. Nat Commun. 2023 Dec 8;14(1):8133. *Contributed Equally
  63. Kawano Y, Wang X, Patel NJ, Qian G, Kowalski E, Bade KJ, Vanni KMM, Jonsson AH, Williams ZK, Cook CE, Srivatsan S, Wallace ZS*, Sparks JA*. Breakthrough COVID-19 after tixagevimab/cilgavimab among patients with systemic autoimmune rheumatic diseases. J Rheumatol. 2024 Mar 1;51(3):305-312. *Co-senior authors.
  64. Wang Q, Martínez-Bonet M, Kim T, Sparks JA, Ishigaki K, Chen X, Sudman M, Gutierrez-Arcelus M, Prahalad S, Raychaudhuri S, Weirauch MT, Langefeld CD, Thompson SD, Nigrovic PA. Identification of a regulatory pathway governing TRAF1 via an arthritis-associated non-coding variant. Cell Genom. 2024 Feb 14;4(2):100502.
  65. Doyle TJ, Juge PA, Peljto A, Lee S, Walts A, Esposito AJ, Poli de Frias S, Gill RR, Hatabu H, Nishino M, Dellaripa PF, Weinblatt ME, Shadick NA, Demoruelle MK, Sparks JA, Rosas IO, Granger B, Deane K, Crestani B, Wolters PJ, Dieude P, Lee JS. Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease. Thorax. 2024 Jan 18;79(2):182-185.
  66. Hanberg JS, Fu X, Wang X, Patel NJ, Kawano Y, Schiff A, Kowalski EN, Cook CE, Vanni KMM, Guzzo K, Qian G, Bade KJ, Saavedra A, Venkat R, Srivatsan S, Zhang Y, Sparks JA*, Wallace ZS*. Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: An emulated target trial. Lancet Rheumatol. 2024 Jan;6(1):e21-e30. *Co-senior authors.

2022

  1. Kronzer VL, Huang W, Crowson CS, Davis JM III, Vasallo R, Doyle TJ, Losina E, Sparks JA. Timing of sinusitis and other respiratory tract diseases and risk of rheumatoid arthritis. Semin Arthritis Rheum. 2021.
  2. Young K, Yeoh SA, Putman M, Sattui S, Conway R, Graef E, Kilian A, Konig M, Sparks JA, Ugarte-Gil M, Upton L, Berenbaum F, Bhana S, Costello W, Hausmann J, Machado P, Robinson P, Sirotich E, Sufka P, Yazdany J, Liew J, Grainger R, Wallace Z, Jayatilleke A. The impact of COVID-19 on rheumatology training: Results from the COVID-19 Global Rheumatology Alliance. Rheumatol Adv Prac. 2021.
  3. Hahn J, Malspeis S, Choi MY, Stevens E, Karlson EW, Lu B, Yoshida K, Kubzanksy L, Sparks JA, Costenbader KH. Association of healthy lifestyle behaviors and risk of developing rheumatoid arthritis among women. Arthritis Care Res. 2021.
  4. Putman M, Kennedy K, Sirotich E, Liew JW, Sattui S, Moni TT, Akpabio AA, Alpizar-Rodriguez D, Angevare S, Beesley R, Berenbaum F, Bulina I, Chock YPE, Conway R, Duarte-García A, Singh AD, Duff E, Durrant K, Gheita TA, Hill CL, Howard R, Hoyer BF, Hsieh E, el Kibbi L, Kilian A, Kim AHJ, Liew D, Lo C, Mateus EF, Miller B, Mingolla S, Nudel M, Singh AD, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, ZamoraTehozol EA, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larché MJ, Levine M, Foster G, Thabane L, Hausmann JS*, Sparks JA*, Simard JF*. COVID-19 vaccine perceptions and uptake in people with rheumatic disease: Results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. Lancet Rheumatol. 2022 .(*co-senior author)
  5. Van Lint JA, van Hunsel FPAM, Tas SW, Vonkeman HE, Hoentjen F, van Doorn MBA, Hebing RCF, Nurmohamed MT, van den Bemt BJF, van Puijenbroek EP, Jessurun NT. Hypoglycaemia following JAK inhibitor treatment in patients with diabetes. Ann Rheum Dis. 2021 Dec 16:annrheumdis-2021-221840. doi: 10.1136/annrheumdis-2021-221840. PMID: 34916208.
  6. Van Kempen ZLE, Wieske L, Stalman EW, Kummer LYL, van Dam PJ, Volkers AG, Boekel L, Toorop AA, Strijbis EMM, Tas SW, Wolbink GJ, Löwenberg M, van Sandt C, Ten Brinke A, Verstegen NJM, Steenhuis M, Kuijpers TW, van Ham SM, Rispens T, Eftimov F, Killestein J; T2B! immunity against SARS-CoV-2 study group. Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate? Mult Scler Relat Disord. 2021 Nov 23;57:103416. doi: 10.1016/j.msard.2021.103416.  PMID: 34847379. PMC8608662.
  7. Merino-Vico A, van Hamburg JP, Tas SW. B lineage cells in ANCA-associated vasculitis. Int. J. Mol. Sci. 2021.
  8. Van Der Heijden H, Fatou B, Sibai D, Hoyt K, Taylor M, Cheung K, Lemme J, Cay M, Goodlett B, Lo J, Hazen M, Halyabar O, Meidan E, Schreiber R, Jaimes C, Ecklund K, Henderson LA, Chang M, Nigrovic PA, Sundel R, Steen H, Upadhyay J. Proteomics Based Markers of Clinical Pain Severity in Juvenile Idiopathic Arthritis. Pediatric Rheum.
  9. Ugarte-Gill MF, Alarcon GS, Seet AM, Izadi Z, Duarte-Garcia A, Gilbert EL, Valenzuela-Almada MO, Wise L, Sparks JA, Hsu TY, D’Silva KM, Patel NJ, Sirotich E, Liew JW, Hausmann JS, Sufka P, Grainger R, Bhana S, Costello W, Wallace ZS, Jacobsohn L, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, LawsonTovey S, Schaefer M, Machado PM, Robinson PC, Gianfrancesco M, Yazdany J. Characteristics Associated with Poor COVID-19 Outcomes in Individuals with Systemic Lupus Erythematosus: Data from the COVID-19 Global Rheumatology Alliance. Ann Rheum Dis. 2022.
  10. Mergaert AM, Zheng Z, Denny MF, Amjadi MF, Bashar SJ, Newton MA, Malmström V, Grönwall C, McCoy SS, Shelef MA. (2022). Rheumatoid factor and anti-modified protein antibody reactivities converge on IgG epitopes. Arthritis & Rheumatology (Hoboken, N.J.), Jan 9.
  11. Mergaert AM, Denny MF, Kingstad-Bakke B, Bawadekar M, Bashar SJ, Warner TF, Suresh M, Shelef MA. (2022). Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses. Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses. J Immunol Res. 2022 Jan 17;2022:5258221.
  12. Grieshaber-Bouyer R*,**, Exner T, Hackert NS, Radtke FA, Jelinsky SA, Halyabar O, Wactor A, Karimizadeh E, Brennan J, Schettini J, Jonsson AH, Rao DA, Henderson LA, Müller-Tidow C, Lorenz, HM, Wabnitz G, Lederer JA, Hadjipanayis A, Nigrovic PA*. Aging and interferon gamma response drive the phenotype of neutrophils in the inflamed joint. Ann Rheum Dis 2022. (* co-corresponding)
  13. McDermott G, Gill R, Gagne S, Byrne S, Huang W, Kronzer VL, Prisco LC, Zaccardelli A, Martin LW, Masto L, Kronzer VL, Shadick N, Dellaripa P, Doyle TJ, Sparks JA. Demographic, lifestyle, and serologic risk factors for rheumatoid arthritis-associated bronchiectasis: Role of RA-related autoantibodies. J Rheumatol. 2022.
  14. Liew JW, Gianfrancesco MA, Harrison C, Izadi Z, Rush S, Lawson-Tovey S, Jacobsohn L, Ja C, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Schäfer M, Mateus EF, Bulina I, Stafford F, Tufan A, Graver C, Yardimci GK, Zepa J, Al-Emadi S, Cook C, Abutiban F, Dey D, Katigbak G, Kaufman L, Kowalski E, Martinez MU, Patel NJ, Reyes-Cordero G, Salido E, Smith E, Snow D, Sparks JA, Wise L, Bhana S, GoreMassy M, Grainger R, Hausmann JS, Sirotich E, Sufka P, Wallace ZS, Machado PM, Robinson PC, Yazdany J. SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: Results from the COVID-19 Global Rheumatology Alliance Provider Registry. RMD Open. 2022.
  15. Tedeschi SK#, Stratton J, Ellrodt JE, Whelan MG, Hayashi K, Yoshida K, Chen L, Adejoorin I, Marks KE, Jonsson AH, Rao DA*, Solomon DH*. Rheumatoid arthritis disease activity assessed by patientreported outcomes and flow cytometry before and after an additional dose of COVID-19 vaccine. Ann Rheum Dis. 2022 Feb 15:annrheumdis-2022-222232. doi: 10.1136/annrheumdis-2022-222232. PMID: 35168944
  16. Simmons DP, Nguyen HN, Gomez-Rivas E, Jeong Y, Jonsson AH, Chen AF, Lange JK, Dyer GS, Blazar P, Earp BE, Coblyn JS, Massarotti EM, Sparks JA, Todd DJ; Accelerating Medicines Partnership (AMP) RA/SLE Network, Rao DA, Kim EY, Brenner MB. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation. Sci Immunol. 2022 Feb 11;7(68):eabf2846. doi: 10.1126/sciimmunol.abf2846.  PMID: 35148199
  17. Marks KE, Rao DA. T peripheral helper cells in autoimmune diseases. Immunol Rev. 2022 Feb 1. doi: 10.1111/imr.13069.  PMID: 35103314 Review.
  18. Wacleche VS, Wang R, Rao DA. Identification of T Peripheral Helper (Tph) Cells. Methods Mol Biol. 2022;2380:59-76. doi: 10.1007/978-1-0716-1736-6_6. PMID: 34802122
  19. Lagattuta KA, Kang JB, Nathan A, Pauken KE, Jonsson AH, Rao DA, Sharpe AH, Ishigaki K, Raychaudhuri S. Repertoire analyses reveal T cell antigen receptor sequence features that influence T cell fate. Nat Immunol. 2022 Feb 17. doi: 10.1038/s41590-022-01129-x.  PMID: 35177831
  20. Steinz MM, Ezdoglian A, Khodadust F, Molthoff CFM, Srinivasarao M, Low PS, Zwezerijnen GJC, Yaqub M, Beaino W, Windhorst AD, Tas SW, Jansen G, van der Laken CJ. Folate Receptor Beta for Macrophage Imaging in Rheumatoid Arthritis. Front Immunol. 2022 Feb 2;13:819163. doi: 10.3389/fimmu.2022.819163. PMID: 35185910. PMC8849105.
  21. Boekel L, Hooijberg F, Besten YR, Vogelzang EH, Steenhuis M, Leeuw M, Atiqi S, van Vollenhoven R, Lems WF, Bos WH, Wijbrandts CA, Gerritsen M, Krieckaert C, Voskuyl AE, van der Horst-Bruinsma IE, Tas SW, Boers M, Rispens T, Nurmohamed MT, Wolbink G. COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases. Lancet Rheumatol. 2022 Feb 8. doi: 10.1016/S2665-9913(22)00009-1. PMID: 35156061. PMC8824534.
  22. Fiechter RH, Bolt JW, van de Sande MGH, Aalbers CJ, Landewé RBM, Maas M, van Baarsen LGM, Tas SW. Ultrasound-guided lymph node biopsy sampling to study the immunopathogenesis of rheumatoid arthritis: a well-tolerated valuable research tool. Arthritis Res Ther. 2022 Feb 3;24(1):36. doi: 10.1186/s13075-022-02728-7. PMID: 35115042. PMC8812012.
  23. Nagy NA, Castenmiller C, Vigario FL, Sparrius R, van Capel TMM, de Haas AM, van Kooyk Y, van Ree R, Tas SW, Geijtenbeek TBH, Jiskoot W, Slütter B, de Jong EC. Uptake Kinetics Of Liposomal Formulations of Differing Charge Influences Development of in Vivo Dendritic Cell Immunotherapy. J Pharm Sci. 2022 Jan 31:S0022-3549(22)00032-6. doi: 10.1016/j.xphs.2022.01.022. PMID: 35114209.
  24. Hammoura I, Fiechter RH, Bryant SH, Westmoreland S, Kingsbury G, Waegell W, Tas SW, Baeten DL, van de Sande MGH, van Tok MN, van Duivenvoorde LM. Dual Blockade of TNF and IL-17A Inhibits Inflammation and Structural Damage in a Rat Model of Spondyloarthritis. Int J Mol Sci. 2022 Jan 13;23(2):859. doi: 10.3390/ijms23020859. PMID: 35055042. PMC8776047.
  25. Najm A, Costantino F, Alivernini S, Alunno A, Bianchi E, Bignall J, Boyce B, Canete JD, Carubbi F, Durez P, Fonseca JE, Just SA, Largo R, Manzo A, Maybury M, Naredo E, Orr C, Pitzalis C, Rivellese F, Romão VC, van Rompay J, Tas SW, Veale DJ, D’Agostino MA, Filer A. EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology. Ann Rheum Dis. 2022 Feb 24:annrheumdis-2021-221875. doi: 10.1136/annrheumdis-2021-221875. PMID: 35210263.
  26. Case SM, Nigrovic PA. Implications of evolving disease classification for drug approval in juvenile idiopathic arthritis. Pediatric Drugs 2022.
  27. Shaw AT, Yan J, Kuhstoss SA, Charles JF, Gravallese EM. Scand J Rheumatol. Dickkopf-1 directs periosteal bone formation in two murine models of inflammatory arthritis. 2022 Mar 11:1-5. doi: 10.1080/03009742.2022.2040136. PMID: 35272576
  28. González-Sánchez HM, Baek JH, Weinmann-Menke J, Ajay AK, Charles JF, Noda M, Franklin RA, Rodríguez-Morales P, Kelley VR. Lab Invest. IL-34 and protein-tyrosine phosphatase receptor typezeta-dependent mechanisms limit arthritis in mice. 2022 Mar 14. doi: 10.1038/s41374-022-00772-0. PMID: 35288653
  29. Sheftel CM, Sartori LC, Hunt ER, Manuel RSJ, Bell AM, Domingues RR, Wake LA, Scharpf BR, Vezina CM, Charles JF, Hernandez LL. Physiol Rep. Peripartal treatment with low-dose sertraline accelerates mammary gland involution and has minimal effects on maternal and offspring bone. 2022 Mar;10(5):e15204. doi: 10.14814/phy2.15204. PMID: 35234346 Free PMC article.
  30. Seyok T, Collins JE, Erikson SJ, Charles JF, Earp BE. Hand (N Y). Future Fracture Risk in Upper Extremity Fracture and Non-Fracture Patients. 2022 Feb 26:15589447211049521. doi: 10.1177/15589447211049521.  PMID: 35220774
  31. McDermott G, Gill R, Gagne S, Byrne S, Huang W, Cui J, Prisco LC, Zaccardelli A, Martin LW, Kronzer VL, Moll M, Cho MH, Shadick N, Dellaripa P, Doyle TJ, Sparks JA. Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset. Rheumatology. 2022 Mar 15:keac152. doi: 10.1093/rheumatology/keac152.
  32. Patel NJ, D’Silva KM, Li MD, Hsu TY, DiIorio M, Fu X, Cook C, Prisco LC, Martin LW, Vanni KMM, Zaccardelli A, Zhang Y, Kalpathy-Cramer J, Sparks JA*, Wallace ZS*. Assessing the severity of COVID-19 lung injury in rheumatic diseases versus the general population using deep learning-derived chest radiograph scores. Arthritis Care Res. 2022 Mar 21. doi: 10.1002/acr.24883. . *Co-senior author.
  33. Joerns EK, Adams TN, Sparks JA, Newton CA, Karp D, Bermas B, Makris UE. Interstitial pneumonia with autoimmune features: What the rheumatologist needs to know. Curr Rheumatol Rep. 2022.
  34. Sparks JA, Singh N, Wallace ZS. Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases. Lancet Rheumatol. 2022.
  35. Rider LG, Parks CG, Wilkerson J, Schiffenbauer AI, Kwok R, Farhadi PN, Nazir S, Ritter R, Sirotich E, Kennedy K, Larche MJ, Levine M, Sattui SE, Liew JW, Moni TT, Miller AK, Putman M, Hausmann J, Simard J, Sparks JA, Miller FW. Associations of baseline factors with self-reported flares following COVID-19 vaccination among adults with rheumatic disease: Results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. Rheumatology. 2022.
  36. Wieske L, van Dam KPJ, Steenhuis M, Stalman EW, Kummer LYL, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, Boekel L, Wolbink GJ, van der Kooi AJ, Raaphorst J, Löwenberg M, Takkenberg RB, D’Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl AE, Broens B, Sanchez AP, van Els CACM, de Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart RCF, Teng YKO, van Paassen P, Busch MH, Jallah PBP, Brusse E, van Doorn PA, Baars AE, Hijnen DJ, Schreurs CRG, van der Pol WL, Goedee HS, Keijzer S, Keijser JBD, Boogaard A, Cristianawati O, Ten Brinke A, Verstegen NJM, Zwinderman KAH, van Ham SM, Kuijpers TW, Rispens T, Eftimov F; T2B! Immunity against SARS-CoV-2 study group. Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study. Lancet Rheumatol. 2022 Mar 17. doi: 10.1016/S2665-9913(22)00034-0. PMID: 35317410. PMC8930018.
  37. Wieske L, Kummer LYL, van Dam KPJ, Stalman EW, van der Kooi AJ, Raaphorst J, Löwenberg M, Takkenberg RB, Volkers AG, D’Haens GRAM, Tas SW, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Killestein J, van Kempen ZLE, Voskuyl AE, Broens B, Sanchez AP, Wolbink G, Boekel L, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart CF, Teng YKO, van Paassen P, Busch MH, Jallah BP, Brusse E, van Doorn PA, Baars AE, Hijnen D, Schreurs CRG, van der Pol WL, Goedee HS, Steenhuis M, Rispens T, Ten Brinke A, Verstegen NJM, Zwinderman KAH, van Ham SM, Kuijpers TW, Eftimov F; T2B! immunity against SARS-CoV-2 study group. Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases. BMC Med. 2022 Mar 2;20(1):100. doi: 10.1186/s12916-022-02310-7. PMID: 35236350. PMC8889379.
  38. Jeucken KCM, Kaaij MH, Rip J, van Rooijen CCN, Kan YY, Corneth OBJ, van Hamburg JP, Tas SW. Splenic Architecture and Function Requires Tight Control of Transmembrane TNF Expression. Int J Mol Sci. 2022 Feb 17;23(4):2229. doi: 10.3390/ijms23042229. PMID: 35216345. PMC8876982.
  39. Boekel L, …, Tas SW, … et al. SARS-CoV-2 delta breakthrough infections in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants – data from two controlled prospective cohort studies. Lancet Rheumatol.
  40. Van Kempen Z, …, Tas SW, … et al. Longitudinal T-cell responses after a third SARS-CoV-2 vaccination in MS patients on ocrelizumab or fingolimod. Neurology: Neuroimmunology & Neuroinflammation.
  41. Anang, D.C.; Ramwadhdoebe, T.H.; Hähnlein, J.S.; van Kuijk, B.; Smits, N.; van Lienden, K.P.; Maas, M.; Gerlag, D.M.; Tak, P.P.; de Vries, N.; van Baarsen, L.G.M. Increased Frequency of CD4+ Follicular Helper T and CD8+ Follicular T Cells in Human Lymph Node Biopsies during the Earliest Stages of Rheumatoid Arthritis. Cells 2022, 11, 1104. https://doi.org/10.3390/cells11071104
  42. Roberts JE, Fan M, Son MB. Insurance Delays in Initiation of Tumor Necrosis Factor Inhibitors in Children with Juvenile Idiopathic Arthritis. JAMA Network Open. 2022 Apr 21.
  43. Grieshaber-Bouyer R, Exner T, Hackert NS, Radtke FA, Jelinsky SA, Halyabar O, Wactor A, Karimizadeh E, Brennan J, Schettini J, Jonsson AH, Rao DA, Henderson LA, Müller-Tidow C, Lorenz, H-M, Wabnitz G, Lederer JA, Hadjipanayis A, Nigrovic PA. Aging and interferon gamma response drive the phenotype of neutrophils in the inflamed joint. Ann Rheum Dis 2022 Feb 15. PMID: 35168946
  44. Taylor M, Hoyt KJ, Han J, Benson L, Case S, Chandler M, Chang MH, Platt C, Cohen EM, DayLewis M, Dedeoglu F, Gorman M, Hausmann J, Janssen E, Lee PY, Lo J, Priebe G, Lo MS, Meidan E, Nigrovic PA, Roberts J, Son MBF, Sundel RP, Alfieri M, Chan Yeun J, Shobei M, Degar B, Chang JC, Halyabar O, Hazen MM, Henderson LA. An Evidence-Based Guideline Improves Outcomes for Patients with Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. J Rheumatol 2022.
  45. Binstadt BA, Nigrovic PA. The Conundrum of Lung Disease and Drug Hypersensitivity-like Reactions in Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol 2022.
  46. Dunlap GS, Billi AC, Xing X, Ma F, Maz MP, Tsoi LC, Wasikowski R, Hodgin JB, Gudjonsson JE, Kahlenberg JM, Rao DA. Single-cell transcriptomics reveals distinct effector profiles of infiltrating T cells in lupus skin and kidney. JCI Insight. 2022 Apr 22;7(8):e156341. doi: 10.1172/jci.insight.156341. PMID: 35290245.
  47. Kim AHJ, Sparks JA. Immunosuppression and SARS-CoV-2 breakthrough infections. Lancet Rheumatol. 2022.
  48. Paik JJ, Sparks JA, Kim AHJ. Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases. Curr Opin Pharmacol. 2022.
  49. Kowalski EN*, Qian G*, Vanni KMM, Sparks JA. A roadmap for investigating pre-clinical autoimmunity using patient-oriented and epidemiologic study designs: Example of rheumatoid arthritis. Front Immunol. 2022 . *Contributed equally.
  50. Juge PA, Granger B, Debray MP, Ebstein E, Louis-Sidney F, Kedra J, Doyle TJ, Borie R, Constantin A, Combe B, Flipo RM, Mariette X, Vittecoq O, Saraux A, Carvajal AG, Sibilia J, Berenbaum F, Kannengiesser C, Boileau C, Sparks JA, Crestani C, Fautrel F, Dieudé P. A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol. 2022.
  51. You X, Dadwal UC, Lenburg ME, Kacena MA, Charles JF. Murine Gut Microbiome Meta-analysis Reveals Alterations in Carbohydrate Metabolism in Response to Aging. mSystems.
  52. Chang MH, Bocharnikov AV, Case SM, Laird-Gion J, Alvarez-Baumgartner M, Nigrovic PA. Patterns of arthritis flare reveal joint-specific memory and sustained risk for new joint accumulation. Arthritis Rheumatol 2022.
  53. Sasaki T, Bracero S, Keegan J, Chen L, Cao Y, Stevens E, Qu Y, Wang G, Nguyen J, Sparks JA, Holers VM, Alves SE, Lederer JA, Costenbader KH, Rao DA. Longitudinal immune cell profiling in early systemic lupus erythematosus. Arthritis Rheumatol. 2022.
  54. DiIorio M, Cook CE, Vanni KMM, Patel NJ, D’Silva KM, Fu X, Wang J, Prisco LC, Kowalski E, Zaccardelli A, Martin LW, Qian G, Hsu TY-T, Wallace ZS+, Sparks JA+. DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study. Semin Arthritis Rheum. 2022 May 18;55:152025. doi: 10.1016/j.semarthrit.2022.152025. +co-senior author
  55. McDermott G, Sparks JA. Quantitative chest imaging and prediction of mortality in rheumatoid arthritis-associated interstitial lung disease. Rheumatology. 2022 Jun 2:keac329. doi: 10.1093/rheumatology/keac329.
  56. Sparks JA, Tedeschi SK. VROOM to improve COVID-19 vaccine immunogenicity by interrupting methotrexate. Lancet Respir Med. 2022.
  57. Jeucken KCM, Van Rooijen CN, Kan YY, Kocken LA, Jongejan A, Van Steen A, Van Buul JD, Olsson HK, Van Hamburg JP, Tas SW. Differential contribution of NF-kappaB signaling pathways to CD4+ memory T cell induced activation of endothelial cells. Frontiers in Immunology. DOI: 10.3389/fimmu.2022.860327
  58. Boekel L, Stalman EW, Wieske L, Hooijberg F, van Dam KPJ, Besten YR, Kummer LYL, Steenhuis M, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, van der Kooi AJ, Raaphorst J, Löwenberg M, Takkenberg RB, D’Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl AE, Broens B, Parra Sanchez A, van Els CACM, de Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart CF, Teng YKO, van Paassen P, Busch MH, Jallah PBP, Brusse E, van Doorn PA, Baars AE, Hijnen DJ, Schreurs CRG, van der Pol WL, Goedee HS, Vogelzang EH, Leeuw M, Atiqi S, van Vollenhoven R, Gerritsen M, van der Horst-Bruinsma IE, Lems WF, Nurmohamed MT, Boers M, Keijzer S, Keijser J, van de Sandt C, Boogaard A, Cristianawati O, Ten Brinke A, Verstegen NJM, Zwinderman KAH, van Ham SM, Rispens T, Kuijpers TW, Wolbink G, Eftimov F; T2B! immunity against SARS-CoV-2 study group. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies. Lancet Rheumatol. 2022 Jun;4(6):e417-e429. doi: 10.1016/S2665- 9913(22)00102-3.  PMID: 35527808. PMC9054068.
  59. Palomares Cabeza V, Kummer LYL, Wieske L, Hagen RR, Duurland M, Konijn VAL, van Dam KPJ, Stalman EW, van de Sandt CE, Boekel L, Verstegen NJM, Steenhuis M, Rispens T, Tas SW, Wolbink G, Killestein J, Kuijpers TW, van Ham SM, Eftimov F, Brinke AT, van Kempen ZLE; Target-to-B! (T2B!) SARS-CoV-2 study group. Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod. Neurol Neuroimmunol Neuroinflamm. 2022 May 6;9(4):e1178. doi: 10.1212/NXI.0000000000001178. PMID: 35523569. PMC9082763.
  60. Boekel L, Hooijberg F, Vogelzang EH, Besten YR, Leeuw M, Atiqi S, van Vollenhoven RF, Wijbrandts CA, Gerritsen M, Krieckaert C, Dijkshoorn B, Bakhlakh S, Crooijmans JJ, Voskuyl A, van der HorstBruinsma IE, Lems W, Kuijpers TW, van Ham SM, Wieske L, Eftimov F, Kummer LY, van Dam PK, Stalman EW, Steenhuis M, Keijzer S, Cristianawati O, Keijser J, Loeff FC, Tas SW, Nurmohamed MT, Boers M, Rispens T, Wolbink G. Antibody development and disease severity of COVID-19 in nonimmunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study. RMD Open. 2022 Apr;8(1):e002035. doi: 10.1136/rmdopen-2021-002035. PMID: 35383121. PMC8983412.
  61. Grayson PC, Beck DB, Ferrada MA, Nigrovic PA, Kastner DL. Notes from the Field: VEXAS Syndrome and Disease Taxonomy in Rheumatology. Arthritis Rheumatol 2022.
  62. Ilya Korsunsky*, Kevin Wei*, Mathilde Pohin*, Edy Y. Kim* Francesca Barone*, Triin Major, Emily Taylor, Rahul Ravindran, Samuel Kemble, Gerald F.M. Watts, A. Helena Jonsson, Yunju Jeong, Humra Athar, Dylan Windell, Joyce B. Kang, Matthias Friedrich, Jason Turner, Saba Nayar, Benjamin A. Fisher, Karim Raza, Jennifer L. Marshall, Adam P. Croft, Tomoyoshi Tamura, Lynette M. Sholl, Marina Vivero, Ivan O. Rosas, Simon J. Bowman, Mark Coles, Andreas P. Frei, Kara Lassen, Andrew Filer, Fiona Powrie#, Christopher D. Buckley#, Michael B. Brenner#, Soumya Raychaudhuri#. Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases.Med. 2022 Jul 8;3(7):481-518.e14.
  63. Jonsson AH, Zhang F, Dunlap G, Gomez-Rivas E, Watts GFM, Faust HJ, Rupani KV, Mears JR, Meednu N, Wang R, Keras G, Coblyn JS, Massarotti EM, Todd DJ, Anolik JH, McDavid A; Accelerating Medicines Partnership RA/SLE Network, Wei K, Rao DA, Raychaudhuri S, Brenner MB. Granzyme K+ CD8 T cells form a core population in inflamed human tissue. Sci Transl Med. 2022 Jun 15;14(649):eabo0686. doi: 10.1126/scitranslmed.abo0686.  PMID: 35704599. PMC9972878 doi: 10.1126/scitranslmed.abo0686
  64. Khodadust F, Ezdoglian A, Steinz MM, van Beijnum JR, Zwezerijnen GJC, Jansen G, Tas SW, van der Laken CJ. Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis. Int. J. Mol. Sci. 2022; 23(13):7071. https://doi.org/10.3390/ijms23137071.
  65. Ebru Dirikgil, Sander W Tas, Cornelis A Verburgh, Darius Soonawala, A Elisabeth Hak, Hilde H F Remmelts, Daphne IJpelaar, Gozewijn D Laverman, Abraham Rutgers, Jaap M van Laar, Hein JBernelot Moens, Peter M J Verhoeven, Ton J Rabelink, Willem Jan W Bos, Y K Onno Teng, for the Autoimmune Research & Collaboration Hub (ARCH) study group. Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients. Rheumatology Advances in Practice, Volume 6, Issue 2, 2022, rkac045, https://doi.org/10.1093/rap/rkac045.
  66. Mehta P, Redhead G, Nair A, Sparks JA, Porter J. Can we finally exonerate methotrexate as a factor in causing or exacerbating fibrotic interstitial lung disease in patients with rheumatoid arthritis?. Clin Rheumatol. 2022 Jun 22. doi: 10.1007/s10067-022-06245-5.
  67. Izadi Z, Gianfrancesco MA, Hyrich KL, Strangfeld A, Gossec J, Carmona L, Mateus E, Lawson-Tovey S, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Al Emadi S, Wise L, Gilbert EL, Duarte-Garcia A, Sparks JA, Hsu TY, D’Silva KM, Serling-Boyd N, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Robinson PC, Machado PM, Yazdany J. Predicting COVID19 acute respiratory distress syndrome in patients with rheumatic diseases using supervised machine learning: Results from the Global Rheumatology Alliance Provider Registry analysed using artificial intelligence. ACR Open Rheumatol. 2022.
  68. Barbhaiya M, Hart JE, Malspeis S, Tedeschi SK, VoPham T, Sparks JA, Karlson EW, Laden F, Costenbader KH. Association of ultraviolet-B radiation and risk of SLE among women in the Nurses’ Health Studies. Arthritis Care Res. 2022 Jun 20. doi: 10.1002/acr.24974.
  69. Li H, Dalbeth N, Wallace ZS, Sparks JA, Zeng C, Wang Y, Xie D, Wei J, Lei G, Zhang Y. Risk of gout flares after COVID-19 vaccination: A case-crossover study. Semin Arthritis Rheum. 2022.
  70. Kawano Y, Patel NJ, Wang X, Cook CE, Vanni KMM, Kowalski EN, Banasiak EB, Qian G, DiIorio M, Hsu TY, Weinblatt ME, Todd DJ, Wallace ZS+, Sparks JA+. Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron. Ann Rheum Dis. 2022. +co-senior author
  71. Figueroa-Parra G, Gilbert EL, Valenzuela-Almada MO, Vallejo S, Patel NJ, Cook C, Fu X, Hagi R, McDermott GC, Dilorio MA, Masto L, Vanni K, Kowalski E, Qian G, Zhang Y, Wallace ZS+, DuarteGarcia A+, Sparks JA+. Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: A multicenter comparative cohort study. Lancet Rheumatol. 2022. (+co-senior author)
  72. Izadi Z, Gianfrancesco MA, Schmajuk G, Jacobsohn L, Katz P, Rush S, Ja C, Taylor T, Shidara K, Danila MI, Wysham K, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, KearsleyFleet L, Schaefer M, Al-Emadi S, Sparks JA, Hsu TY, Patel NJ, Wise L, Gilbert E, Duarte-García A, Valenzuela-Almada MO, Ugarte-Gil MF, Ljung L, Scirè CA, Carrara G, Hachulla E, Richez C, Cacoub P, Thomas T, Santos MJ, Bernardes M, Hasseli R, Regierer A, Schulze-Koops H, Müller-Ladner U, PonsEstel G, Tanten R, Nieto RE, Pisoni CN, Xavier R, Lopes Marques CD, Pileggi GCS, Robinson PC, Machado PM, Sirotich E, Liew JW, Hausmann JS, Sufka P, Grainger R, Bhana S, Costello W, Wallace ZS, Yazdany J. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance Registry. Lancet Rheumatol. 2022 Jul 25. doi: 10.1016/S2665-9913(22)00192-8. PMID: 35909441. PMC9313519 
  73. Jatuworapruk K, Montgomery A, Gianfrancesco M, Conway R, Durcan L, Graef ER, Jayatilleke A, Keen H, Kilian A, Young K, Duarte-García A, Sparks JA, Carmona L, Gossec L, Hyrich KL, Lawson-Tovey S, Mateus EF, Schafer M, Strangfeld A, Bhana S, Gore-Massy M, Hausmann J, Liew JW, Sirotich E, Sufka P, Wallace ZS, Machado PM, Yazdany J, Grainger R, Robinson PC. Characteristics and outcomes of hospitalized people with gout diagnosed with COVID-19: Data from the COVID-19 Global Rheumatology Alliance physician-reported registry. ACR Open Rheumatol. 2022.
  74. Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, Johnson SR, Imundo LF, Winthrop K, Arasaratnam RJ, Baden LR, Berard R, Bridges SL Jr., Cheah JTL, Curtis JR, Ferguson PJ, Hakkarinen I, Onel KB, Schultz G, Sivaraman V, Smith BJ, Sparks JA, Vogel T, Williams EA, Calabrese C, Cunha JS, Fontanarosa J, Gillispie-Taylor MC, Gkrouzman E, Iyer PC, Legge A, Lo M, Lockwood M, Sadun RE, Showalter K, Singh N, Sullivan N, Tam H, Turgunbaev M, Turner AS, Reston J. 2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2022.
  75. Choi MY, Malspeis S, Sparks JA, Cui J, Yoshida K, Costenbader KH. Association of sleep deprivation and the risk of developing systemic lupus erythematosus among women. Arthritis Care Res. 2022.
  76. DiIorio M, Kennedy K, Liew J, Putman M, Sirotich E, Sattui SE, Foster G, Harrison C, Larché M, Levine M, Moni TT, Thabane L, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Gore-Marry M, Howard R, Kodhek MA, Lalonde N, Tomasella LA, Wallace J, Akpabio A, Alpizar-Rodriguez D, Beesley R, Berenbaum F, Bulina I, Chock EYP, Conway R, Duarte-Garcia A, Duff E, Gheita TA, Graef ER, Hsieh E, El Kibbi L, Liew DFL, Lo C, Nudel M, Singh AD, Singh JA, Singh N, Ugarte-Gil MF, Hausmann J, Simard JF, Sparks JA. Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open. 2022 .
  77. Maguire S, Al-Emadi S, Alba P, Aguiar MC, Al-Lawati T, Alle G, Anic B, Lorenzo QA, Bermas B, Bhana S, Bulina I, Clowse M, Cogo K, Colunga I, Cook C, Cortez KJ, Faizeh S, Gianfrancesco M, Gore-Massey M, Gossec L, Grainger R, Hausmann J, Hsu T, Hyrich K, Isnardi C, Dao K, Kawano Y, Kilding R, Kusevich DA, Liew J, McCarthy E, Montgumery A, Moyano S, Noreen N, Padjen I, Papgoras C, Patel N, Pera M, Pisoni C, Pons-Estal G, Quintana R, Ruderman E, Sattui S, Savio V, Sciascia S, Sencarova M, Sirotich E, Sparks JA, Strangfeld A, Sufka P, Tanner H, Tissera Y, Wallace Z, Werner ML, Wise L, Worthing A, Zell J, Zepa J, Machado P, Yazdany J, Robinson P, Conway R. Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status: Data from the COVID-19 Global Rheumatology Alliance Registry. Rheumatology. 2022.
  78. Multimodal regulation of the osteoclastogenesis process by secreted group IIA phospholipase A2; Maria Mangini Rosa D’Angelo Caterina Vinciguerra Christine Payré Gérard Lambeau Barbara Balestrieri Julia F. Charles and Stefania Mariggiò. Frontiers in Cell and Developmental Biology.
  79. Boekel L, Besten YR, Hooijberg F, Wartena R, Steenhuis M, Vogelzang E, Leeuw M, Atiqi S, Tas SW, Lems WF, van Ham SM, Eftimov F, Stalman EW, Wieske L, Kuijpers TW, Voskuyl AE, van Vollenhoven RF, Gerritsen M, Krieckaert C, Rispens T, Boers M, Nurmohamed MT, Wolbink G. SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period. Lancet Rheumatol. 2022 Aug 23. doi: 10.1016/S2665-9913(22)00221-1. PMID: 36034738. PMC9398211.
  80. Mangini M, D’Angelo R, Vinciguerra C, Payré C, Lambeau G, Balestrieri B, Charles JF, Mariggiò S. Multimodal regulation of the osteoclastogenesis process by secreted group IIA phospholipase A2. Front Cell Dev Biol. 2022;10:966950. doi: 10.3389/fcell.2022.966950. eCollection 2022. PubMed PMID: 36105351. PMC9467450.
  81. Musters A, Balzaretti G, van Schaik BDC, Jongejan A, van der Weele L, Tas SW, van Kampen AHC, de Vries N. In rheumatoid arthritis inflamed joints share dominant patient-specific B-cell clones. Front Immunol. 2022 Jul 27;13:915687. doi: 10.3389/fimmu.2022.915687. PMID: 35967291. PMC9363889.
  82. Seyok T, Collins JE, Erikson SJ, Charles JF, Earp BE. Impact of an Outpatient Fracture Liaison Service on Osteoporosis Evaluation Among Patients With Upper Extremity Fragility Fracture. Hand (N Y). 2022 Sep 16;:15589447221120851. doi: 10.1177/15589447221120851.  PubMed PMID: 36113071.
  83. Van Laar GG, van Hamburg JP, Tas SW. Extrathymic AIRE-expressing cells: Friends or foes in autoimmunity and cancer? Autoimmun Rev. 2022 Sep;21(9):103141. doi: 10.1016/j.autrev.2022.103141.  PMID: 35840039. doi: 10.1016/j.autrev.2022.103141
  84. Verstegen NJM, Hagen RR, van den Dijssel J, Kuijper LH, Kreher C, Ashhurst T, Kummer LYL, Steenhuis M, Duurland M, de Jongh R, de Jong N, van der Schoot CE, Bos AV, Mul E, Kedzierska K, van Dam KPJ, Stalman EW, Boekel L, Wolbink G, Tas SW, Killestein J, van Kempen ZLE, Wieske L, Kuijpers TW, Eftimov F, Rispens T, van Ham SM, Ten Brinke A, van de Sandt CE; T2B! immunity against SARS-CoV-2 study group. Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273. Elife. 2022 Jul 15;11:e77969. doi: 10.7554/eLife.77969. PMID: 35838348. PMC9337853.
  85. Patel NJ, Wang X, Fu X, Kawano Y, Cook C, Vanni KMM, Qian G, Banasiak E, Kowalski E, Zhang Y, Sparks JA*, Wallace ZS*. Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study. Semin Arthritis Rheum. 2022. *Contributed equally.
  86. DiIorio M, Kennedy K, Liew J, Putman M, Sirotich E, Sattui SE, Foster G, Harrison C, Larché M, Levine M, Moni TT, Thabane L, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Gore-Marry M, Howard R, Kodhek MA, Lalonde N, Tomasella LA, Wallace J, Akpabio A, Alpizar-Rodriguez D, Beesley R, Berenbaum F, Bulina I, Chock EYP, Conway R, Duarte-Garcia A, Duff E, Gheita TA, Graef ER, Hsieh E, El Kibbi L, Liew DFL, Lo C, Nudel M, Singh AD, Singh JA, Singh N, Ugarte-Gil MF, Hausmann J, Simard JF, Sparks JA. Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open. 2022 Sep;8(2):e002587.
  87. Choi MY, Malspeis S, Sparks JA, Cui J, Yoshida K, Costenbader KH. Association of sleep deprivation and the risk of developing systemic lupus erythematosus among women. Arthritis Care Res. 2022 Sep 12. doi: 10.1002/acr.25017.
  88. Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, Johnson SR, Imundo LF, Winthrop K, Arasaratnam RJ, Baden LR, Berard R, Bridges SL Jr., Cheah JTL, Curtis JR, Ferguson PJ, Hakkarinen I, Onel KB, Schultz G, Sivaraman V, Smith BJ, Sparks JA, Vogel T, Williams EA, Calabrese C, Cunha JS, Fontanarosa J, Gillispie-Taylor MC, Gkrouzman E, Iyer PC, Legge A, Lo M, Lockwood M, Sadun RE, Showalter K, Singh N, Sullivan N, Tam H, Turgunbaev M, Turner AS, Reston J. 2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2022.
  89. Maguire S, Al-Emadi S, Alba P, Aguiar MC, Al-Lawati T, Alle G, Anic B, Lorenzo QA, Bermas B, Bhana S, Bulina I, Clowse M, Cogo K, Colunga I, Cook C, Cortez KJ, Faizeh S, Gianfrancesco M, Gore-Massey M, Gossec L, Grainger R, Hausmann J, Hsu T, Hyrich K, Isnardi C, Dao K, Kawano Y, Kilding R, Kusevich DA, Liew J, McCarthy E, Montgumery A, Moyano S, Noreen N, Padjen I, Papgoras C, Patel N, Pera M, Pisoni C, Pons-Estal G, Quintana R, Ruderman E, Sattui S, Savio V, Sciascia S, Sencarova M, Sirotich E, Sparks JA, Strangfeld A, Sufka P, Tanner H, Tissera Y, Wallace Z, Werner ML, Wise L, Worthing A, Zell J, Zepa J, Machado P, Yazdany J, Robinson P, Conway R. Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status: Data from the COVID-19 Global Rheumatology Alliance Registry. Rheumatology. 2022 Sep 19;keac534. PMID: 36124987 DOI: 10.1093/rheumatology/keac534
  90. Li H, Wallace ZS, Sparks JA, Lu N, Wei J, Xie D, Wang J, Zeng C, Lei G, Zhang Y. Risk of COVID-19 among unvaccinated and vaccinated patients with rheumatoid arthritis: A general population study. Arthritis Care Res. 2022 Sep 26. doi: 10.1002/acr.25028.  PMID: 36161711. PMC9538842
  91. Kronzer VL, Lennon RJ, Sparks JA, Myasoedova E, Davis JM III, Crowson CS. Association between work physical activity, dietary factors, and risk of rheumatoid arthritis. Semin Arthritis Rheum. 2022 Sep 19;57:152100. doi: 10.1016/j.semarthrit.2022.152100.  PMID: 36166875. PMC9869704
  92. Ugarte-Gil MF, Alarcon GS, Seet AM, Izadi Z, Montgomery AD, Duarte-Garcia A, Gilbert EL, Valenzuela-Almada MO, Wise L, Sparks JA, Hsu TY, D’Silva KM, Patel NJ, Sirotich E, Liew JW, Hausmann JS, Sufka P, Grainger R, Bhana S, Wallace ZS, Jacobsohn L, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Schaefer M, Machado PM, Robinson PC, Gianfrancesco M, Yazdany J. Association between race/ethnicity and COVID-19 outcomes in systemic lupus erythematosus (SLE) patients from the United States: Data from the COVID-19 Global Rheumatology Alliance. Arthritis Care Res. 2022 Oct 14. doi: 10.1002/acr.25039. PMID: 36239292
  93. Huang Z, You X, Chen L, Du Y, Brodeur K, Jee H, Wang Q, Linder G, Darbousset R, Cunin P, Chang MH, Wactor A, Wauford BM, Todd MJC, Wei K, Li Y, Levescot A, Iwakura Y, Pascual V, Baldwin NE, Quartier P, Li T, Gianatasio MT, Hasserjian P, Henderson LA, Sykes DB, Mellins ED, Canna SW, Charles JF, Nigrovic PA*, Lee PY*. mTORC1 connects the spectrum of pathology in experimental models of Still’s disease and macrophage activation syndrome. Nature Comm 2022.

2021

  1. Cheung P, Schaffert S, Chang SE, Dvorak M, Donato M, Macaubas C, Foecke MH, Li TM, Zhang L, Coan JP, Schulert GS, Grom AA, Henderson LA, Nigrovic PA, Elias JE, Gozani O, Mellins ED, Khatri P, Utz PJ, Kuo AJ. Repression of CTSG, ELANE and PRTN3-mediated histone H3 proteolytic cleavage promotes monocyte-to-macrophage differentiation. Nat Immunol. 2021 Jun;22(6):711-722. doi: 10.1038/s41590-021-00928-y.  PubMed PMID: 34017121. PMC8159908.
  2. Jee H, Huang Z, Baxter S, Huang Y, Taylor ML, Henderson LA, Rosenzweig S, Sharma A, Chambers EP, Hershfield MS, Zhou Q, Dedeoglu F, Aksentijevich I, Nigrovic PA, O’Donnell-Luria A, Lee PY. Comprehensive analysis of ADA2 genetic variants and estimation of carrier frequency driven by a function-based approach. J Allergy Clin Immunol. 2021 May 15;. doi: 10.1016/j.jaci.2021.04.034. PubMed PMID: 34004258; NIHMSID: NIHMS1705330.
  3. Prisco L, Moll M, Wang J, Hobbs BD, Huang W, Martin LW, Kronzer VL, Huang S, Silverman EK, Doyle TJ, Cho MH, Sparks JA. Relationship between rheumatoid arthritis and pulmonary function measures on spirometry in the UK Biobank. Arthritis Rheumatol. 2021 May 13;. doi: 10.1002/art.41791.  PubMed PMID: 33982900; NIHMSID: NIHMS1701389.
  4. Kronzer VL, Huang W, Dellaripa PF, Huang S, Feathers V, Lu B, Iannaccone CK, Gill RR, Hatabu H, Nishino M, Crowson CS, Davis JM 3rd, Weinblatt ME, Shadick NA, Doyle TJ, Sparks JA. Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease. J Rheumatol. 2021 May;48(5):656-663. doi: 10.3899/jrheum.200863. PubMed PMID: 33191286. PMC8096643.
  5. Roberts JE, Nigrovic PA, Lo MS, Chang MH. Weekly Adalimumab, an Effective Alternative for Refractory Uveitis in Children. J Clin Rheumatol. 2021 Mar 16;. doi: 10.1097/RHU.0000000000001707.  PubMed PMID: 33790207; NIHMSID: NIHMS1704141.
  6. Yoshida K, Lin TC, Wei MY, Malspeis S, Chu SH, Camargo CA Jr, Raby BA, Choi HK, Tedeschi SK, Barbhaiya M, Lu B, Costenbader KH, Karlson EW, Sparks JA. Roles of Postdiagnosis Accumulation of Morbidities and Lifestyle Changes in Excess Total and Cause-Specific Mortality Risk in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021 Feb;73(2):188-198. doi: 10.1002/acr.24120. PubMed PMID: 31811708. PMC7275877.
  7. Kronzer VL, Crowson CS, Sparks JA, Myasoedova E, Davis J 3rd. Family History of Rheumatic, Autoimmune, and Nonautoimmune Diseases and Risk of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021 Feb;73(2):180-187. doi: 10.1002/acr.24115. PubMed PMID: 31785183. PMC7260093
  8. Sparks JA, Malspeis S, Hahn J, Wang J, Roberts AL, Kubzansky LD, Costenbader KH. Depression and Subsequent Risk for Incident Rheumatoid Arthritis Among Women. Arthritis Care Res (Hoboken). 2021 Jan;73(1):78-89. PMID: 32937012. PMC7775283.
  9. Sparks JA. Clinical application of personalized rheumatoid arthritis risk information: Translational epidemiology leading to precision medicine. Expert Rev Precis Med Drug Dev. 2021;6(3):147-149. doi: 10.1080/23808993.2021.1857237. PubMed PMID: 34124370. PMC8192070.

2020

  1. Huang S, Kronzer VL, Dellaripa PF, Deane KD, Bolster MB, Nagaraja V, Khanna D, Doyle TJ, Sparks JA. Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment. Curr Treatm Opt Rheumatol. 2020 Dec;6(4):337-353. PMID: 33282632; PMC7709915.
  2. Huang S, Doyle TJ, Hammer MM, Byrne SC, Huang W, Marshall AA, Iannaccone CK, Huang J, Feathers V, Weinblatt ME, Dellaripa PF, Shadick NA, Sparks JA. Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality. Semin Arthritis Rheum. 2020 Dec;50(6):1216-1225. PMID: 33059295; PMC7736489.
  3. Shrock E, Fujimura E, Kula T, Timms RT, Lee IH, Leng Y, Robinson ML, Sie BM, Li MZ, Chen Y, Logue J, Zuiani A, McCulloch D, Lelis FJN, Henson S, Monaco DR, Travers M, Habibi S, Clarke WA, Caturegli P, Laeyendecker O, Piechocka-Trocha A, Li JZ, Khatri A, Chu HY, Villani AC, Kays K, Goldberg MB, Hacohen N, Filbin MR, Yu XG, Walker BD, Wesemann DR, Larman HB, Lederer JA, Elledge SJ. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science. 2020 Nov 27;370(6520). doi: 10.1126/science.abd4250.PubMed PMID: 32994364. PMC7857405.
  4. Lee PY, Day-Lewis M, Henderson LA, Friedman KG, Lo J, Roberts JE, Lo MS, Platt CD, Chou J, Hoyt KJ, Baker AL, Banzon TM, Chang MH, Cohen E, de Ferranti SD, Dionne A, Habiballah S, Halyabar O, Hausmann JS, Hazen MM, Janssen E, Meidan E, Nelson RW, Nguyen AA, Sundel RP, Dedeoglu F, Nigrovic PA, Newburger JW, Son MBF. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020 Nov 2;130(11):5942-5950. PMID: 32701511; PMC7598077.
  5. Chu SH, Cui J, Sparks JA, Lu B, Tedeschi SK, Speyer CB, Moss L, Feser ML, Kelmenson LB, Mewshaw EA, Edison JD, Deane KD, Clish C, Lasky-Su J, Karlson EW, Costenbader KH. Circulating plasma metabolites and risk of rheumatoid arthritis in the Nurses’ Health Study. Rheumatology (Oxford). 2020 Nov 1;59(11):3369-3379. PMID: 32310291; PMC7590418.
  6. Nigrovic PA, Lee PY, Hoffman HM. Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach. J Allergy Clin Immunol. 2020 Nov;146(5):925-937. Review. PMID: 33160483; PMC7727443.
  7. Han S, Zhuang H, Lee PY, Li M, Yang L, Nigrovic PA, Reeves WH. NF-E2-Related Factor 2 Regulates Interferon Receptor Expression and Alters Macrophage Polarization in Lupus. Arthritis Rheumatol. 2020 Oct;72(10):1707-1720. PMID: 32500632; PMC7718430.
  8. D’Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Fu X, Gravallese EM, Choi HK, Sparks JA, Wallace ZS. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’. Ann Rheum Dis. 2020 Sep;79(9):1156-1162. PMID: 32457048; PMC7456555.
  9. Barbhaiya M, Tedeschi S, Sparks JA, Leatherwood C, Karlson EW, Willett WC, Lu B, Costenbader KH. Association of Dietary Quality with Risk of Incident Systemic Lupus Erythematosus in the Nurses’ Health Studies. Arthritis Care Res (Hoboken). 2020 Sep 16;. PMID: 32936999.
  10. Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-García A. Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-analysis. Arthritis Rheumatol. 2020 Aug 2; PMID: 32741139; PMC7435536.
  11. Yuan J, Zhang C, Sparks JA, Malspeis S, Tsoi KK, Kim JH, Fisher BA, Gao F, Sumerlin T, Liu Y, Liu Y, Pan Y, He Y, Sung JJY. Regular use of proton pump inhibitor and risk of rheumatoid arthritis in women: a prospective cohort study. Aliment Pharmacol Ther. 2020 Aug;52(3):449-458. PMID: 32598046; PMC7406413.
  12. Cunin P, Nigrovic PA. Megakaryocyte emperipolesis: a new frontier in cell-in-cell interaction. Platelets. 2020 Aug 17;31(6):700-706. PMID: 31752579; PMC7239726.
  13. Scheetz MH, Konig MF, Robinson PC, Sparks JA, Kim AHJ. A Pharmacokinetics-Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID-19 Pandemic. ACR Open Rheumatol. 2020 Aug;2(8):491-495. PMID: 32725866; PMC7437131.
  14. Hahn J, Leatherwood C, Malspeis S, Liu X, Lu B, Roberts AL, Sparks JA, Karlson EW, Feldman CH, Munroe ME, James JA, Kubzansky LD, Costenbader KH. Associations between daily alcohol consumption and systemic lupus erythematosus-related cytokines and chemokines among US female nurses without SLE. Lupus. 2020 Jul;29(8):976-982. PMID: 32507075; PMC7497791.
  15. Lee PY, Kellner ES, Huang Y, Furutani E, Huang Z, Bainter W, Alosaimi MF, Stafstrom K, Platt CD, Stauber T, Raz S, Tirosh I, Weiss A, Jordan MB, Krupski C, Eleftheriou D, Brogan P, Sobh A, Baz Z, Lefranc G, Irani C, Kilic SS, El- Owaidy R, Lokeshwar MR, Pimpale P, Khubchandani R, Chambers EP, Chou J, Geha RS, Nigrovic PA, Zhou Q. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). J Allergy Clin Immunol. 2020 Jun;145(6):1664-1672.e10. PMID: 31945408. PMC7282972.
  16. Prisco LC, Martin LW, Sparks JA. Inhalants other than personal cigarette smoking and risk for developing rheumatoid arthritis. Curr Opin Rheumatol. 2020 May;32(3):279-288. PMID: 32141952. PMC7233294.
  17. Knevel R, le Cessie S, Terao CC, Slowikowski K, Cui J, Huizinga TWJ, Costenbader KH, Liao KP, Karlson EW, Raychaudhuri S. Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis. Sci Transl Med. 2020 May 27;12(545). PMID: 32461333; PMC7341896.
  18. Kim AHJ, Sparks JA, Liew JW, Putman MS, Berenbaum F, Duarte-García A, Graef ER, Korsten P, Sattui SE, Sirotich E, Ugarte-Gil MF, Webb K, Grainger R. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020 Jun 16;172(12):819-821. PMID: 32227189; PMC7138335.
  19. Henderson LA, Hoyt KJ, Lee PY, Rao DA, Jonsson AH, Nguyen JP, Rutherford K, Julé AM, Charbonnier LM, Case S, Chang MH, Cohen EM, Dedeoglu F, Fuhlbrigge RC, Halyabar O, Hazen MM, Janssen E, Kim S, Lo J, Lo MS, Meidan E, Son MBF, Sundel RP, Stoll ML, Nusbaum C, Lederer JA, Chatila TA, Nigrovic PA. Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. JCI Insight. 2020 Mar 26;5(6). PMID: 32213704; PMC7213804.
  20. Huang Z, Li T, Nigrovic PA, Lee PY. Polyarteritis nodosa and deficiency of adenosine deaminase 2 – Shared genealogy, generations apart. Clin Immunol. 2020 Jun;215:108411. PMID: 32276138. PMC7387119.
  21. Meng F, Bertucci C, Gao Y, Li J, Luu S, LeBoff MS, Glowacki J, Zhou S. Fibroblast growth factor 23 counters vitamin D metabolism and action in human mesenchymal stem cells. J Steroid Biochem Mol Biol. 2020 May;199:105587. PMID: 32004706.
  22. Zaccardelli A, Liu X, Ford JA, Cui J, Lu B, Chu SH, Schur PH, Speyer CB, Costenbader KH, Robinson WH, Sokolove J, Karlson EW, Camargo CA Jr, Sparks JA. Elevated anti-citrullinated protein antibodies prior to rheumatoid arthritis diagnosis and risks for chronic obstructive pulmonary disease or asthma. Arthritis Care Res (Hoboken). 2020 Jan 21:10.1002/acr.24140. PMID: 31961487. PMC7371499.
  23. Schmider AB, Bauer NC, Sunwoo H, Godin MD, Ellis GE, Lee JT, Nigrovic PA, Soberman RJ. Two- and three-color STORM analysis reveals higher-order assembly of leukotriene synthetic complexes on the nuclear envelope of murine neutrophils. J Biol Chem. 2020 Apr 24;295(17):5761-5770. PMID: 32152223. PMC7186161.
  24. Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, Caricchio R, Mahmud S, Hazen MM, Halyabar O, Hoyt KJ, Han J, Grom AA, Gattorno M, Ravelli A, De Benedetti F, Behrens EM, Cron RQ, Nigrovic PA. On the Alert for Cytokine Storm: Immunopathology in COVID-19. Arthritis Rheumatol. 2020 Jul;72(7):1059-1063. PMID: 32293098; PMC7262347.
  25. Graef ER, Liew JW, Putman MS, Simard JF, Sirotich E, Berenbaum F, Duarte-García A, Grainger R, Harrison C, Konig MF, Korsten P, Proulx L, Richards DP, Robinson PC, Sattui SE, Ugarte-Gil MF, Young KJ, Kim AH, Sparks JA. Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis. 2020 Jun;79(6):734-736. Review. PMID: 32295786; PMC7359879.
  26. Kronzer VL, Wang L, Liu H, Davis JM, Sparks JA, Crowson CS. Investigating the impact of disease and health record duration on the eMERGE algorithm for rheumatoid arthritis. J Am Med Inform Assoc. 2020 Apr 1;27(4):601-605. PMID: 32134444; PMC7647254.
  27. Ford JA, Liu X, Chu SH, Lu B, Cho MH, Silverman EK, Costenbader KH, Camargo CA Jr, Sparks JA. Asthma, Chronic Obstructive Pulmonary Disease, and Subsequent Risk for Incident Rheumatoid Arthritis Among Women: A Prospective Cohort Study. Arthritis Rheumatol. 2020 May;72(5):704-713. PMID: 32129572; PMC7188599.
  28. Chen PY, Qin L, Li G, Malagon-Lopez J, Wang Z, Bergaya S, Gujja S, Caulk AW, Murtada SI, Zhang X, Zhuang ZW, Rao DA, Wang G, Tobiasova Z, Jiang B, Montgomery RR, Sun L, Sun H, Fisher EA, Gulcher JR, Fernandez-Hernando C, Humphrey JD, Tellides G, Chittenden TW, Simons M. Smooth Muscle Cell Reprogramming in Aortic Aneurysms. Cell Stem Cell. 2020 Apr 2;26(4):542 557.e11. PMID: 32243809; PMC7182079.
  29. Solomon DH, Glynn RJ, Karlson EW, Lu F, Corrigan C, Colls J, Xu C, MacFadyen J, Barbhaiya M, Berliner N, Dellaripa PF, Everett BM, Pradhan AD, Hammond SP, Murray M, Rao DA, Ritter SY, Rutherford A, Sparks JA, Stratton J, Suh DH, Tedeschi SK, Vanni KMM, Paynter NP, Ridker PM. Adverse Effects of Low-Dose Methotrexate: A Randomized Trial. Ann Intern Med. 2020 Mar 17;172(6):369-380. PMID: 32066146; PMC7229518.
  30. Lee PY, Schulert GS, Canna SW, Huang Y, Sundel J, Li Y, Hoyt KJ, Blaustein RB, Wactor A, Do T, Halyabar O, Chang MH, Dedeoglu F, Case SM, Meidan E, Lo MS, Sundel RP, Richardson ET, Newburger JW, Hershfield MS, Son MB, Henderson LA, Nigrovic PA. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2020 Feb;79(2):225-231. PMID: 31707357; PMC7385992.
  31. Hoyt KJ, Chatila TA, Notarangelo LD, Hazen MM, Janssen E, Henderson LA. The immunologic features of patients with early-onset and polyautoimmunity. Clin Immunol. 2020 Feb;211:108326. PMID: 31838215; PMC7050734.
  32. Cheng HD, Tirosh I, de Haan N, Stöckmann H, Adamczyk B, McManus CA, O’Flaherty R, Greville G, Saldova R, Bonilla FA, Notarangelo LD, Driessen GJ, Holm IA, Rudd PM, Wuhrer M, Ackerman ME, Nigrovic PA. IgG Fc glycosylation as an axis of humoral immunity in childhood. J Allergy Clin Immunol. 2020 Feb;145(2):710-713.e9. PMID: 31669096; PMC7010538.
  33. Henderson LA, Cron RQ. Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management. Paediatr Drugs. 2020 Feb;22(1):29-44. Review. PMID: 31732958; PMC7334831.
  34. Han S, Zhuang H, Lee PY, Li M, Yang L, Nigrovic PA, Reeves WH. Differential Responsiveness of Monocyte and Macrophage Subsets to Interferon. Arthritis Rheumatol. 2020 Jan;72(1):100-113. PMID: 31390156; PMC6935410.
  35. Friedlander HM, Ford JA, Zaccardelli A, Terrio AV, Cho MH, Sparks JA. Obstructive lung diseases and risk of rheumatoid arthritis. Expert Rev Clin Immunol. 2020 Jan;16(1):37-50. PMID: 31774329; PMC6980732.
  36. Tedeschi SK, Barbhaiya M, Sparks JA, Karlson EW, Kubzansky LD, Roberts AL, Willett WC, Lu B, Costenbader KH. Dietary patterns and risk of systemic lupus erythematosus in women. Lupus. 2020 Jan;29(1):67-73. PMID: 31718449; PMC6923577.

2019

 

  1. Shadick NA, Katz P, Iannaccone CI, Maica G, Coblyn J, Weinblatt ME, Cui J. The Impact of Exercise, Lifestyle, and Clinical Factors on Perceived Cognitive Function in Patients with Rheumatoid Arthritis: Results from a Prospective Cohort Study. ACR Open Rheumatol. 2019 Dec;1(10):620-626. PMID: 31872183; PMC6917307.
  2. Traylor M, Knevel R, Cui J, Taylor J, Harm-Jan W, Conaghan PG, Cope AP, Curtis C, Emery P, Newhouse S, Patel H, Steer S, Gregersen P, Shadick NA, Weinblatt ME, Van Der Helm-van Mil A, Barrett JH, Morgan AW, Lewis CM, Scott IC. Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases. PLoS One. 2019;14(10):e0223246. PMID: 31596875; PMC6785117.
  3. Yoshida K, Lin TC, Wei M, Malspeis S, Chu SH, Camargo CA, Raby BA, Choi HK, Tedeschi SK, Barbhaiya M, Lu B, Costenbader KH, Karlson EW, Sparks JA. The roles of post-diagnosis accumulation of morbidities and lifestyle changes on excess total and cause-specific mortality risk in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2019 Dec 7:10.1002/acr.24120. PMID: 31811708. PMC7275877.
  4. Huang S, He X, Doyle TJ, Zaccardelli A, Marshall AA, Friedlander HM, Blaustein RB, Smith EA, Cui J, Iannaccone CK, Mahmoud TG, Weinblatt ME, Dellaripa PF, Shadick NA, Sparks JA. Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry. Clin Rheumatol. 2019 Dec;38(12):3401-3412. Erratum in: Eur J Pediatr. 2020 Jan 23;:. PMID: 31410660; PMC6859190.
  5. Kronzer VL, Crowson CS, Sparks JA, Myasoedova E, Davis JM 3rd. Comorbidities As Risk Factors for Rheumatoid Arthritis and Their Accrual After Diagnosis. Mayo Clin Proc. 2019 Dec;94(12):2488-2498. PMID: 31759675; PMC6907158.
  6. Kronzer VL, Crowson CS, Sparks JA, Myasoedova E, Davis J 3rd. Family history of rheumatologic, autoimmune, and non-autoimmune diseases and risk of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2019 Nov 30:10.1002/acr.24115. PMID: 31785183.  PMC7260093.
  7. Zaccardelli A, Liu X, Ford JA, Cui J, Lu B, Chu SH, Schur PH, Speyer CB, Costenbader KH, Robinson WH, Sokolove J, Karlson EW, Camargo CA Jr, Sparks JA. Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis. Arthritis Res Ther. 2019 Nov 21;21(1):246. PMID: 31753003; PMC6868779.
  8. Sun B, Chang HH, Salinger A, Tomita B, Bawadekar M, Holmes CL, Shelef MA, Weerapana E, Thompson PR, Ho IC. Reciprocal regulation of Th2 and Th17 cells by PAD2-mediated citrullination. JCI Insight. 2019 Nov 14;4(22):e129687. PMID: 31723060; PMC6948856.
  9. Urso K, Caetano-Lopes J, Lee PY, Yan J, Henke K, Sury M, Liu H, Zgoda M, Jacome-Galarza C, Nigrovic PA, Duryea J, Harris MP, Charles JF. A role for G protein-coupled receptor 137b in bone remodeling in mouse and zebrafish. Bone. 2019 Oct;127:104-113. PMID: 31173907; PMC6708790.
  10. Hou L, Rao DA, Yuki K, Cooley J, Henderson LA, Jonsson AH, Kaiserman D, Gorman MP, Nigrovic PA, Bird PI, Becher B, Remold-O’Donnell E. SerpinB1 controls encephalitogenic T helper cells in neuroinflammation. Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20635-20643. PMID: 31548399; PMC6789640.
  11. Nigrovic PA. Storm Warning: Lung Disease in Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2019 Nov;71(11):1773-1775. PMID: 31390168; PMC6817387.
  12. Nigrovic PA, Martínez-Bonet M, Thompson SD. Implications of juvenile idiopathic arthritis genetic risk variants for disease pathogenesis and classification. Curr Opin Rheumatol. 2019 Sep;31(5):401-410. PMID: 31169548; PMC6800096.
  13. Sparks JA, He X, Huang J, Fletcher EA, Zaccardelli A, Friedlander HM, Gill RR, Hatabu H, Nishino M, Murphy DJ, Iannaccone CK, Mahmoud TG, Frits ML, Lu B, Rosas IO, Dellaripa PF, Weinblatt ME, Karlson EW, Shadick NA, Doyle TJ. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study. Arthritis Rheumatol. 2019 Sep;71(9):1472-1482. PMID: 30951251; PMC6716994.Liu X, Tedeschi SK, Lu B, Zaccardelli A, Speyer CB, Costenbader KH, Karlson EW, Sparks JA. Long-Term Physical Activity and Subsequent Risk for Rheumatoid Arthritis Among Women: A Prospective Cohort Study. Arthritis Rheumatol. 2019 Sep;71(9):1460-1471. PMID: 30920773; PMC6717001.
  14. Nigrovic PA, Martínez-Bonet M, Thompson SD. Implications of juvenile idiopathic arthritis genetic risk variants for disease pathogenesis and classification. Curr Opin Rheumatol. 2019 Sep;31(5):401-410. PMID: 31169548; PMC6800096.
  15. Cahill KN, Cui J, Kothari P, Murphy K, Raby BA, Singer J, Israel E, Boyce JA, Laidlaw TM. Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial. Am J Respir Crit Care Med. 2019 Sep 15;200(6):704-711. PMID: 30978291; PMC6775876.
  16. Spiliopoulou A, Colombo M, Plant D, Nair N, Cui J, Coenen MJ, Ikari K, Yamanaka H, Saevarsdottir S, Padyukov L, Bridges SL Jr, Kimberly RP, Okada Y, van Riel PLC, Wolbink G, van der Horst-Bruinsma IE, de Vries N, Tak PP, Ohmura K, Canhão H, Guchelaar HJ, Huizinga TW, Criswell LA, Raychaudhuri S, Weinblatt ME, Wilson AG, Mariette X, Isaacs JD, Morgan AW, Pitzalis C, Barton A, McKeigue P. Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39. Ann Rheum Dis. 2019 Aug;78(8):1055-1061. PMID: 31036624; PMC6669378.
  17. Lee PY, Nelson-Maney N, Huang Y, Levescot A, Wang Q, Wei K, Cunin P, Li Y, Lederer JA, Zhuang H, Han S, Kim EY, Reeves WH, Nigrovic PA. High-dimensional analysis reveals a pathogenic role of inflammatory monocytes in experimental diffuse alveolar hemorrhage. JCI Insight. 2019 Aug 8;4(15). pii: 129703. PMID: 31391335; PMC6693829.
  18. Kronzer VL, Crowson CS, Sparks JA, Vassallo R, Davis JM 3rd. Investigating Asthma, Allergic Disease, Passive Smoke Exposure, and Risk of Rheumatoid Arthritis. Arthritis Rheumatol. 2019 Aug;71(8):1217-1224. PMID: 30747496; PMC6676490.
  19. Jorge A, Castro VM, Barnado A, Gainer V, Hong C, Cai T, Cai T, Carroll R, Denny JC, Crofford L, Costenbader KH, Liao KP, Karlson EW, Feldman CH. Identifying lupus patients in electronic health records: Development and validation of machine learning algorithms and application of rule-based algorithms. Semin Arthritis Rheum. 2019 Aug;49(1):84-90. PMID: 30665626; PMC6609504.
  20. Zaccardelli A, Friedlander HM, Ford JA, Sparks JA. Potential of Lifestyle Changes for Reducing the Risk of Developing Rheumatoid Arthritis: Is an Ounce of Prevention Worth a Pound of Cure? Clin Ther. 2019 Jul;41(7):1323-1345. Review. PMID: 31196646; PMC6684958.
  21. Chang HH, Ho CH, Tomita B, Silva AA, Sparks JA, Karlson EW, Rao DA, Lee YC, Ho IC. Utilizing a PTPN22 gene signature to predict response to targeted therapies in rheumatoid arthritis. J Autoimmun. 2019 Jul;101:121-130. PMID: 31030958; PMC6556429.
  22. Liu X, Tedeschi SK, Barbhaiya M, Leatherwood CL, Speyer CB, Lu B, Costenbader KH, Karlson EW, Sparks JA. Impact and Timing of Smoking Cessation on Reducing Risk of Rheumatoid Arthritis Among Women in the Nurses’ Health Studies. Arthritis Care Res (Hoboken). 2019 Jul;71(7):914-924. PMID: 30790475; PMC6597309.
  23. Henderson LA. A Bullseye for Children With Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2019 Jul;71(7):1030-1033. PMID: 30802004; PMC6594873.
  24. Fang C, Manes TD, Liu L, Liu K, Qin L, Li G, Tobiasova Z, Kirkiles-Smith NC, Patel M, Merola J, Fu W, Liu R, Xie C, Tietjen GT, Nigrovic PA, Tellides G, Pober JS, Jane-Wit D. ZFYVE21 is a complement-induced Rab5 effector that activates non-canonical NF-κB via phosphoinosotide remodeling of endosomes. Nat Commun. 2019 May 21;10(1):2247. PMID: 31113953; PMC6529429.
  25. Cunin P, Bouslama R, Machlus KR, Martínez-Bonet M, Lee PY, Wactor A, Nelson-Maney N, Morris A, Guo L, Weyrich A, Sola-Visner M, Boilard E, Italiano JE, Nigrovic PA. Megakaryocyte emperipolesis mediates membrane transfer from intracytoplasmic neutrophils to platelets. Elife. 2019 May 1;8. pii: e44031. PMID: 31042146; PMC6494422.
  26. Marshall AA, Zaccardelli A, Yu Z, Prado MG, Liu X, Miller Kroouze R, Kalia SS, Green RC, Triedman NA, Lu B, Deane KD, Iversen MD, Karlson EW, Sparks JA. Effect of communicating personalized rheumatoid arthritis risk on concern for developing RA: A randomized controlled trial. Patient Educ Couns. 2019 May;102(5):976-983. PMID: 30558852; PMC6491232.
  27. Sparks JA, Lesperance T, Accortt NA, Solomon DH. Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment. Arthritis Care Res (Hoboken). 2019 Apr;71(4):512-520. PMID: 29799667; PMC6252288.
  28. Angeles-Han ST, Lo MS, Henderson LA, Lerman MA, Abramson L, Cooper AM, Parsa MF, Zemel LS, Ronis T, Beukelman T, Cox E, Sen HN, Holland GN, Brunner HI, Lasky A, Rabinovich CE; Juvenile Idiopathic Arthritis Disease-Specific and Uveitis Subcommittee of the Childhood Arthritis Rheumatology and Research Alliance. Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior Uveitis. Arthritis Care Res (Hoboken). 2019 Apr;71(4):482-491. PMID: 29806733; PMC6261704.
  29. Kimsey L, Weissman JS, Patel A, Drew A, Koehlmoos T, Sparks JA. Delay in initiation of DMARD or anti-inflammatory therapy in patients newly diagnosed with rheumatoid arthritis: An analysis of United States Military Health System TRICARE beneficiaries. Semin Arthritis Rheum. 2019 Apr;48(5):821-827. PMID: 30190154; PMC6338526.
  30. Grieshaber-Bouyer R, Nigrovic PA. Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease. Front Immunol. 2019 Mar 4;10:346. Review. PMID: 30886615; PMC6409342.
  31. Miller ER, Fanta CH, McSparron JI, Pan B, Coblyn JS, Sparks JA. Musculoskeletal and pulmonary outcomes of sarcoidosis after initial presentation of osseous involvement. Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(1):60-63. PMID: 30918438; PMC6433168.
  32. Chang MH, Nigrovic PA. Antibody-dependent and -independent mechanisms of inflammatory arthritis. JCI Insight. 2019 Mar 7;4(5). pii: 125278. Review. PMID: 30843881; PMC6483516.
  33. Sparks JA, Doyle TJ, He X, Pan B, Iannaccone C, Frits ML, Dellaripa PF, Rosas IO, Lu B, Weinblatt ME, Shadick NA, Karlson EW. Incidence and predictors of dyspnea on exertion in a prospective cohort of patients with rheumatoid arthritis. ACR Open Rheumatol. 2019 Mar;1(1):4-15. PMID: 30923795; PMC6433160.
  34. Li H, Benson LA, Henderson LA, Solomon IH, Kennedy AL, Soldatos A, Bielekova B, Murphy J, Davies KJ, Lehmann LE, Lee MA, Alexandrescu S, Degar BA, Gorman MP, Duncan CN. Central nervous system-restricted familial hemophagocytic lymphohistiocytosis responds to hematopoietic cell transplantation. Blood Adv. 2019 Feb 26;3(4):503-507. PMID: 30760465; PMC6391665.
  35. Halyabar O, Chang MH, Schoettler ML, Schwartz MA, Baris EH, Benson LA, Biggs CM, Gorman M, Lehmann L, Lo MS, Nigrovic PA, Platt CD, Priebe GP, Rowe J, Sundel RP, Surana NK, Weinacht KG, Mann A, Yuen JC, Meleedy-Rey P, Starmer A, Banerjee T, Dedeoglu F, Degar BA, Hazen MM, Henderson LA. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Pediatr Rheumatol Online J. 2019 Feb 14;17(1):7. PMID: 30764840; PMC6376762.
  36. Cunin P, Lee PY, Kim E, Schmider AB, Cloutier N, Pare A, Gunzer M, Soberman RJ, Lacroix S, Boilard E, Lefort CT, Nigrovic PA. Differential attenuation of β2 integrin-dependent and -independent neutrophil migration by Ly6G ligation. Blood Adv. 2019 Feb 12;3(3):256-267. PMID: 30696624; PMC6373735.
  37. Stanaway IB, Hall TO, Rosenthal EA, Palmer M, Naranbhai V, Knevel R, Namjou-Khales B, Carroll RJ, Kiryluk K, Gordon AS, Linder J, Howell KM, Mapes BM, Lin FTJ, Joo YY, Hayes MG, Gharavi AG, Pendergrass SA, Ritchie MD, de Andrade M, Croteau-Chonka DC, Raychaudhuri S, Weiss ST, Lebo M, Amr SS, Carrell D, Larson EB, Chute CG, Rasmussen-Torvik LJ, Roy-Puckelwartz MJ, Sleiman P, Hakonarson H, Li R, Karlson EW, Peterson JF, Kullo IJ, Chisholm R, Denny JC, Jarvik GP; eMERGE Network, Crosslin DR. The eMERGE genotype set of 83,717 subjects imputed to ~40 million variants genome wide and association with the herpes zoster medical record phenotype. Genet Epidemiol. 2019 Feb;43(1):63-81. PMID: 30298529; PMC6375696.
  38. Sparks JA, O’Reilly ÉJ, Barbhaiya M, Tedeschi SK, Malspeis S, Lu B, Willett WC, Costenbader KH, Karlson EW. Association of fish intake and smoking with risk of rheumatoid arthritis and age of onset: a prospective cohort study. BMC Musculoskelet Disord. 2019 Jan 5;20(1):2. PMID: 30611246; PMC6320647
  39. Sparks JA, Barbhaiya M, Tedeschi SK, Leatherwood CL, Tabung FK, Speyer CB, Malspeis S, Costenbader KH, Karlson EW, Lu B. Inflammatory dietary pattern and risk of developing rheumatoid arthritis in women. Clin Rheumatol. 2019 Jan;38(1):243-250. PMID: 30109509; PMC6344305.
  40. Laidlaw TM, Cahill KN, Cardet JC, Murphy K, Cui J, Dioneda B, Kothari P, Raby BA, Israel E, Boyce JA. A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2019 Jan;143(1):316-324.e7. PMID: 29890239; PMC6286686.
  41. Cunin P, Nigrovic PA. Megakaryocytes as immune cells. J Leukoc Biol. 2019 Jun;105(6):1111-1121. Review. PMID: 30645026.

2018

 

  1. Ricciotti E, Castro C, Tang SY, Briggs WTE, West JA, Malik D, Rhoades SD, Meng H, Li X, Lahens NF, Sparks JA, Karlson EW, Weljie AM, Griffin JL, FitzGerald GA. Cyclooxygenase-2, Asymmetric Dimethylarginine, and the Cardiovascular Hazard From Nonsteroidal Anti-Inflammatory Drugs. Circulation. 2018 Nov 20;138(21):2367-2378. PMID: 29930022; PMC6291350.
  2. Williams JN, Chang SC, Sinnette C, Malspeis S, Parks CG, Karlson EW, Fraser P, Costenbader K. Pesticide exposure and risk of systemic lupus erythematosus in an urban population of predominantly African-American women. Lupus. 2018 Nov;27(13):2129-2134. PMID: 30309287; PMC6207463.
  3. Cortes A, Gladman D, Raychaudhuri S, Cui J, Wheeler L, Brown MA. Imputation-based analysis of MICA alleles in the susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2018 Nov;77(11):1691-1692. PMID: 29705741; PMC6716791.
  4. Fonseka CY, Rao DA, Teslovich NC, Korsunsky I, Hannes SK, Slowikowski K, Gurish MF, Donlin LT, Lederer JA, Weinblatt ME, Massarotti EM, Coblyn JS, Helfgott SM, Todd DJ, Bykerk VP, Karlson EW, Ermann J, Lee YC, Brenner MB, Raychaudhuri S. Mixed-effects association of single cells identifies an expanded effector CD4+ T cell subset in rheumatoid arthritis. Sci Transl Med. 2018 Oct 17;10(463). PMID: 30333237; PMC6448773.
  5. Ford JA, Liu X, Marshall AA, Zaccardelli A, Prado MG, Wiyarand C, Lu B, Karlson EW, Schur PH, Deane KD, Sparks JA. Impact of Cyclic Citrullinated Peptide Antibody Level on Progression to Rheumatoid Arthritis in Clinically Tested CCP-Positive Patients Without RA. Arthritis Care Res (Hoboken). 2018 Dec 20. PMID: 30570827; PMC6586539.
  6. Prado MG, Iversen MD, Yu Z, Miller Kroouze R, Triedman NA, Kalia SS, Lu B, Green RC, Karlson EW, Sparks JA. Effectiveness of a Web-Based Personalized Rheumatoid Arthritis Risk Tool With or Without a Health Educator for Knowledge of Rheumatoid Arthritis Risk Factors. Arthritis Care Res (Hoboken). 2018 Oct;70(10):1421-1430. PMID: 29316383; PMC6033684.
  7. Solomon DH, Lu B, Yu Z, Corrigan C, Harrold LR, Smolen JS, Fraenkel L, Katz JN, Losina E. Benefits and Sustainability of a Learning Collaborative for Implementation of Treat-to-Target in Rheumatoid Arthritis: Results of a Cluster-Randomized Controlled Phase II Clinical Trial. Arthritis Care Res (Hoboken). 2018 Oct;70(10):1551-1556. PMID: 29316341; PMC6033691.
  8. Lee PY, Huang Y, Zhou Q, Schnappauf O, Hershfield MS, Li Y, Ganson NJ, Sampaio Moura N, Delmonte OM, Stone SS, Rivkin MJ, Pai SY, Lyons T, Sundel RP, Hsu VW, Notarangelo LD, Aksentijevich I, Nigrovic PA. Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2. J Allergy Clin Immunol. 2018 Oct;142(4):1363-1365.e8. PMID: 29936104; PMC6175612.
  9. Shadick NA, Zibit MJ, Iannaccone CK, Thrower R, Sowell NF, Weinblatt ME, Solomon DH, Cui J. A Development and Feasibility Study of a Peer Support Telephone Program in Rheumatoid Arthritis. J Clin Rheumatol. 2018 Sep;24(6):346-349. PMID: 29389689; PMC6699178.
  10. Vastert SJ, Nigrovic PA. Editorial: Toward Personalized Treatment for Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2018 Aug;70(8):1172-1174. PMID: 29569852; PMC6105394.
  11. Li G, Martínez-Bonet M, Wu D, Yang Y, Cui J, Nguyen HN, Cunin P, Levescot A, Bai M, Westra HJ, Okada Y, Brenner MB, Raychaudhuri S, Hendrickson EA, Maas RL, Nigrovic PA. High-throughput identification of noncoding functional SNPs via type IIS enzyme restriction. Nat Genet. 2018 Aug;50(8):1180-1188. PMID: 30013183; PMC6072570.
  12. Hejblum BP, Cui J, Lahey LJ, Cagan A, Sparks JA, Sokolove J, Cai T, Liao KP. Association Between Anti-Citrullinated Fibrinogen Antibodies and Coronary Artery Disease in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2018 Jul;70(7):1113-1117. PMID: 28992379; PMC5891393.
  13. Sparks JA, Iversen MD, Yu Z, Triedman NA, Prado MG, Miller Kroouze R, Kalia SS, Atkinson ML, Mody EA, Helfgott SM, Todd DJ, Dellaripa PF, Bermas BL, Costenbader KH, Deane KD, Lu B, Green RC, Karlson EW. Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2018 Jun;70(6):823-833. PMID: 29024454; PMC5897224.
  14. Nigrovic PA, Beukelman T, Tomlinson G, Feldman BM, Schanberg LE, Kimura Y; Childhood Arthritis and Rheumatology Research Alliance Systemic Juvenile Idiopathic Arthritis Consensus Treatment Plan Workgroup. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST). Clin Trials. 2018 Jun;15(3):268-277. PMID: 29542334; PMC5990441.
  15. Dart AH, Michelson KA, Aronson PL, Garro AC, Lee TJ, Glerum KM, Nigrovic PA, Kocher MS, Bachur RG, Nigrovic LE. Hip Synovial Fluid Cell Counts in Children From a Lyme Disease Endemic Area. Pediatrics. 2018 May;141(5). pii: e20173810. PMID: 29669751; PMC5914490.
  16. Sparks JA, Lin TC, Camargo CA Jr, Barbhaiya M, Tedeschi SK, Costenbader KH, Raby BA, Choi HK, Karlson EW. Rheumatoid arthritis and risk of chronic obstructive pulmonary disease or asthma among women: A marginal structural model analysis in the Nurses’ Health Study. Semin Arthritis Rheum. 2018 Apr;47(5):639-648. PMID: 29037522; PMC5857435.
  17. Barbhaiya M, Tedeschi SK, Lu B, Malspeis S, Kreps D, Sparks JA, Karlson EW, Costenbader KH. Cigarette smoking and the risk of systemic lupus erythematosus, overall and by anti-double stranded DNA antibody subtype, in the Nurses’ Health Study cohorts. Ann Rheum Dis. 2018 Feb;77(2):196-202. PMID: 28988206; PMC5994168.
  18. Ogdie A, Sparks JA, Angeles-Han ST, Bush K, Castelino FV, Golding A, Jiang Y, Kahlenberg JM, Kim AHJ, Lee YC, Machireddy K, Ombrello MJ, Shah AA, Wallace ZS, Nigrovic PA, Makris UE; American College of Rheumatology Early Career Investigator Subcommittee of the Committee on Research. Barriers and Facilitators of Mentoring for Trainees and Early Career Investigators in Rheumatology Research: Current State, Identification of Needs, and Road Map to an Inter-Institutional Adult Rheumatology Mentoring Program. Arthritis Care Res (Hoboken). 2018 Mar;70(3):445-453. PMID: 28544766; PMC5700864.
  19. Mizoguchi F, Slowikowski K, Wei K, Marshall JL, Rao DA, Chang SK, Nguyen HN, Noss EH, Turner JD, Earp BE, Blazar PE, Wright J, Simmons BP, Donlin LT, Kalliolias GD, Goodman SM, Bykerk VP, Ivashkiv LB, Lederer JA, Hacohen N, Nigrovic PA, Filer A, Buckley CD, Raychaudhuri S, Brenner MB. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat Commun. 2018 Feb 23;9(1):789. PMID: 29476097; PMC5824882.
  20. Sparks JA, Costenbader KH. Rheumatoid arthritis in 2017: Protective dietary and hormonal factors brought to light. Nat Rev Rheumatol. 2018 Feb;14(2):71-72. Review. PMID: 29323341; PMC5783757.
  21. Nguyen UDT, Zhang Y, Lu N, Louie-Gao Q, Niu J, Ogdie A, Gelfand JM, LaValley MP, Dubreuil M, Sparks JA, Karlson EW, Choi HK. Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study. Ann Rheum Dis. 2018 Jan;77(1):119-123. PMID: 29102956; PMC5978759.
  22. Sparks JA, Chang SC, Nguyen US, Barbhaiya M, Tedeschi SK, Lu B, Kreps DJ, Costenbader KH, Zhang Y, Choi HK, Karlson EW. Weight Change During the Early Rheumatoid Arthritis Period and Risk of Subsequent Mortality in Women With Rheumatoid Arthritis and Matched Comparators. Arthritis Rheumatol. 2018 Jan;70(1):18-29. PMID: 29193837. PMC5745282.
  23. Nigrovic PA, Raychaudhuri S, Thompson SD. Review: Genetics and the Classification of Arthritis in Adults and Children. Arthritis Rheumatol. 2018 Jan;70(1):7-17. Review. PMID: 29024575; PMC5805142.
  24. Kreps DJ, Halperin F, Desai SP, Zhang ZZ, Losina E, Olson AT, Karlson EW, Bermas BL, Sparks JA. Association of weight loss with improved disease activity in patients with rheumatoid arthritis: A retrospective analysis using electronic medical record data. Int J Clin Rheumtol. 2018;13(1):1-10. PMID: 29606976; PMC5875117.
  25. Sparks JA, Chang SC, Nguyen US, Barbhaiya M, Tedeschi SK, Lu B, Kreps DJ, Costenbader KH, Zhang Y, Choi HK, Karlson EW. Weight Change During the Early Rheumatoid Arthritis Period and Risk of Subsequent Mortality in Women With Rheumatoid Arthritis and Matched Comparators. Arthritis Rheumatol. 2018 Jan;70(1):18-29. PMID: 29193837. PMC5745282.

2017

 

  1. Cheng HD, Stöckmann H, Adamczyk B, McManus CA, Ercan A,Holm IA, Rudd PM, Ackerman ME*, Nigrovic PA*. High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis. Glycobiology. 2017 Dec 1;27(12):1099-1108. PMID: 28973482; PMC5881781.
  2. Bermas BL, Tedeschi SK, Frits M, Shadick NA. An evaluation of the patient-administered Rheumatoid Arthritis Disease Activity Index for assessing disease activity during pregnancy. Rheumatology (Oxford). 2017 Dec 1;56(12):2237-2239. PMID: 29155980. PMC5850783.
  3. Tedeschi SK, Frits M, Cui J, Zhang ZZ, Mahmoud T, Iannaccone C, Lin TC, Yoshida K, Weinblatt ME, Shadick NA, Solomon DH. Diet and Rheumatoid Arthritis Symptoms: Survey Results From a Rheumatoid Arthritis Registry. Arthritis Care Res (Hoboken). 2017 Dec;69(12):1920-1925. PMID: 28217907; PMC5563270.
  4. Kim H, Cui J, Frits M, Iannaccone C, Coblyn J, Shadick NA, Weinblatt ME, Lee YC. Fibromyalgia and the Prediction of Two-Year Changes in Functional Status in Rheumatoid Arthritis Patients. Arthritis Care Res (Hoboken). 2017 Dec;69(12):1871-1877. PMID: 28182837; PMC5550353.
  5. Bengtsson C, Malspeis S, Orellana C, Sparks JA, Costenbader KH, Karlson EW. Association Between Menopausal Factors and the Risk of Seronegative and Seropositive Rheumatoid Arthritis: Results From the Nurses’ Health Studies. Arthritis Care Res (Hoboken). 2017 Nov;69(11):1676-1684. PMID: 28085997; PMC5509515.
  6. Bai M, Grieshaber-Bouyer R, Wang J, Schmider AB, Wilson ZS, Zeng L, Halyabar O, Godin MD, Nguyen HN, Levescot A, Cunin P, Lefort CT, Soberman RJ, Nigrovic PA. CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation. Blood. 2017 Nov 9;130(19):2092-2100. PMID: 28807980; PMC5680608.
  7. McIntosh LA, Marion MC, Sudman M, Comeau ME, Becker ML, Bohnsack JF, Fingerlin TE, Griffin TA, Haas JP, Lovell DJ, Maier LA, Nigrovic PA, Prahalad S, Punaro M, Rosé CD, Wallace CA, Wise CA, Moncrieffe H, Howard TD, Langefeld CD, Thompson SD. Genome-Wide Association Meta-Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility Loci. Arthritis Rheumatol. 2017 Nov;69(11):2222-2232. PMID: 28719732; PMC5874801.
  8. Iversen MD, Frits M, von Heideken J, Cui J, Weinblatt M, Shadick NA. Physical Activity and Correlates of Physical Activity Participation Over Three Years in Adults With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2017 Oct;69(10):1535-1545. PMID: 27863147; PMC5436948.
  9. Moncrieffe H, Bennett MF, Tsoras M, Luyrink LK, Johnson AL, Xu H, Dare J, Becker ML, Prahalad S, Rosenkranz M, O’Neil KM, Nigrovic PA, Griffin TA, Lovell DJ, Grom AA, Medvedovic M, Thompson SD. Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate. Rheumatology (Oxford). 2017 Sep 1;56(9):1542-1551. PMID: 28582527; PMC5850489.
  10. Schneeweiss M, Merola JF, Karlson EW, Solomon DH. Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR). BMC Dermatol. 2017 Aug 16;17(1):11. PMID: 28814312; PMC5559864.
  11. Hu Y, Sparks JA, Malspeis S, Costenbader KH, Hu FB, Karlson EW, Lu B. Long-term dietary quality and risk of developing rheumatoid arthritis in women. Ann Rheum Dis. 2017 Aug;76(8):1357-1364. PMID: 28137914; PMC5556680.
  12. Sparks JA, Barbhaiya M, Karlson EW, Ritter SY, Raychaudhuri S, Corrigan CC, Lu F, Selhub J, Chasman DI, Paynter NP, Ridker PM, Solomon DH. Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study. Semin Arthritis Rheum. 2017 Aug;47(1):133-142. PMID: 28284844; PMC5765986.
  13. Sun B, Dwivedi N, Bechtel TJ, Paulsen JL, Muth A, Bawadekar M, Li G, Thompson PR, Shelef MA, Schiffer CA, Weerapana E, Ho IC. Citrullination of NF-κB p65 promotes its nuclear localization and TLR-induced expression of IL-1β and TNFα. Sci Immunol. 2017 Jun 9;2(12). PMID: 28783661; PMC5718838.
  14. Tedeschi SK, Cui J, Arkema EV, Robinson WH, Sokolove J, Lingampalli N, Sparks JA, Karlson EW, Costenbader KH. Elevated BMI and antibodies to citrullinated proteins interact to increase rheumatoid arthritis risk and shorten time to diagnosis: A nested case-control study of women in the Nurses’ Health Studies. Semin Arthritis Rheum. 2017 Jun;46(6):692-698. PMID: 27939764; PMC5348285.
  15. Tedeschi SK, Barbhaiya M, Malspeis S, Lu B, Sparks JA, Karlson EW, Willett W, Costenbader KH. Obesity and the risk of systemic lupus erythematosus among women in the Nurses’ Health Studies. Semin Arthritis Rheum. 2017 Dec;47(3):376-383. PMID: 28688713; PMC5675759.
  16. Cunin P, Penke LR, Thon JN, Monach PA, Jones T, Chang MH, Chen MM, Melki I, Lacroix S, Iwakura Y, Ware J, Gurish MF, Italiano JE, Boilard E, Nigrovic PA. Megakaryocytes compensate for Kit insufficiency in murine arthritis. J Clin Invest. 2017 May 1;127(5):1714-1724. PMID: 28375155; PMC5409069.
  17. Cahill KN, Katz HR, Cui J, Lai J, Kazani S, Crosby-Thompson A, Garofalo D, Castro M, Jarjour N, DiMango E, Erzurum S, Trevor JL, Shenoy K, Chinchilli VM, Wechsler ME, Laidlaw TM, Boyce JA, Israel E. KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma. N Engl J Med. 2017 May 18;376(20):1911-1920. PMID: 28514613; PMC5568669.
  18. Liao KP, Sparks JA, Hejblum BP, Kuo IH, Cui J, Lahey LJ, Cagan A, Gainer VS, Liu W, Cai TT, Sokolove J, Cai T. Phenome-Wide Association Study of Autoantibodies to Citrullinated and Noncitrullinated Epitopes in Rheumatoid Arthritis. Arthritis Rheumatol. 2017 Apr;69(4):742-749. PMID: 27792870; PMC5378622.
  19. Cui J, Diogo D, Stahl EA, Canhao H, Mariette X, Greenberg JD, Okada Y, Pappas DA, Fulton RS, Tak PP, Nurmohamed MT, Lee A, Larson DE, Kurreeman F, Deluca TL, O’Laughlin M, Fronick CC, Fulton LL, Mardis ER, van der Horst-Bruinsma IE, Wolbink GJ, Gregersen PK, Kremer JM, Crusius JB, de Vries N, Huizinga TW, Fonseca JE, Miceli-Richard C, Karlson EW, Coenen MJ, Barton A, Plenge RM, Raychaudhuri S. Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid Arthritis. Arthritis Rheumatol. 2017 Apr;69(4):735-741. PMID: 27788309; PMC6669377.
  20. Nigrovic PA. Building an ARC to Grant Success: The Aims Review Committee. Arthritis Care Res (Hoboken). 2017 Apr;69(4):459-461. PMID: 27696715; PMC5376365.
  21. Barbhaiya M, Lu B, Sparks JA, Malspeis S, Chang SC, Karlson EW, Costenbader KH. Influence of Alcohol Consumption on the Risk of Systemic Lupus Erythematosus Among Women in the Nurses’ Health Study Cohorts. Arthritis Care Res (Hoboken). 2017 Mar;69(3):384-392. PMID: 27273851; PMC5140763.
  22. Lu B, Driban JB, Xu C, Lapane KL, McAlindon TE, Eaton CB. Dietary Fat Intake and Radiographic Progression of Knee Osteoarthritis: Data From the Osteoarthritis Initiative. Arthritis Care Res (Hoboken). 2017 Mar;69(3):368-375. PMID: 27273934; PMC5140767.
  23. Hu Y, Cui J, Sparks JA, Malspeis S, Costenbader KH, Karlson EW, Lu B. Circulating carotenoids and subsequent risk of rheumatoid arthritis in women. Clin Exp Rheumatol. 2017 Mar-Apr;35(2):309-312. PMID: 28079511; PMC5556698.
  24. Cahill KN, Johns CB, Cui J, Wickner P, Bates DW, Laidlaw TM, Beeler PE. Automated identification of an aspirin-exacerbated respiratory disease cohort. J Allergy Clin Immunol. 2017 Mar;139(3):819-825.e6. PMID: 27567328; PMC5266739.
  25. Ercan A, Kohrt WM, Cui J, Deane KD, Pezer M, Yu EW, Hausmann JS, Campbell H, Kaiser UB, Rudd PM, Lauc G, Wilson JF, Finkelstein JS, Nigrovic PA. Estrogens regulate glycosylation of IgG in women and men. JCI Insight. 2017 Feb 23;2(4):e89703. PMID: 28239652; PMC5313059.
  26. Rao DA, Gurish MF, Marshall JL, Slowikowski K, Fonseka CY, Liu Y, Donlin LT, Henderson LA, Wei K, Mizoguchi F, Teslovich NC, Weinblatt ME, Massarotti EM, Coblyn JS, Helfgott SM, Lee YC, Todd DJ, Bykerk VP, Goodman SM, Pernis AB, Ivashkiv LB, Karlson EW, Nigrovic PA, Filer A, Buckley CD, Lederer JA, Raychaudhuri S, Brenner MB. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017 Feb 1;542(7639):110-114. PMID: 28150777; PMC5349321.

2016

  1. Lee YN, Frugoni F, Dobbs K, Tirosh I, Du L, Ververs FA, Ru H, Ott de Bruin L, Adeli M, Bleesing JH, Buchbinder D, Butte MJ, Cancrini C, Chen K, Choo S, Elfeky RA, Finocchi A, Fuleihan RL, Gennery AR, El-Ghoneimy DH, Henderson LA, Al-Herz W, Hossny E, Nelson RP, Pai SY, Patel NC, Reda SM, Soler-Palacin P, Somech R, Palma P, Wu H, Giliani S, Walter JE, Notarangelo LD. Characterization of T and B cell repertoire diversity in patients with RAG deficiency. Sci Immunol. 2016 Dec 16;1(6). pii: eaah6109. PMID: 28783691; PMC5586490.
  2. Chang HH, Liu GY, Dwivedi N, Sun B, Okamoto Y, Kinslow JD, Deane KD, Demoruelle MK, Norris JM, Thompson PR, Sparks JA, Rao DA, Karlson EW, Hung HC, Holers VM, Ho IC. A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22. JCI Insight. 2016 Oct 20;1(17):e90045. PMID: 27777982; PMC5070957.
  3. Li G, Cunin P, Wu D, Diogo D, Yang Y, Okada Y, Plenge RM, Nigrovic PA. The Rheumatoid Arthritis Risk Variant CCR6DNP Regulates CCR6 via PARP-1. PLoS Genet. 2016 Sep 14;12(9):e1006292. PMID: 27626929; PMC5023119.
  4. Kim SC, Schneeweiss S, Liu J, Karlson EW, Katz JN, Feldman S, Solomon DH. Biologic Disease-Modifying Antirheumatic Drugs and Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Rheumatoid Arthritis: A Cohort Study. Arthritis Rheumatol. 2016 Sep;68(9):2106-13. PMC5001884.
  5. Li Z, Xia Y, Feng LN, Chen JR, Li HM, Cui J, Cai QQ, Sim KS, Nairismägi ML, Laurensia Y, Meah WY, Liu WS, Guo YM, Chen LZ, Feng QS, Pang CP, Chen LJ, Chew SH, Ebstein RP, Foo JN, Liu J, Ha J, Khoo LP, Chin ST, Zeng YX, Aung T, Chowbay B, Diong CP, Zhang F, Liu YH, Tang T, Tao M, Quek R, Mohamad F, Tan SY, Teh BT, Ng SB, Chng WJ, Ong CK, Okada Y, Raychaudhuri S, Lim ST, Tan W, Peng RJ, Khor CC, Bei JX. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study. Lancet Oncol. 2016 Sep;17(9):1240-7. PMID: 27470079; PMC6790270.
  6. Sparks JA, Chang SC, Deane KD, Gan RW, Kristen Demoruelle M, Feser ML, Moss L, Buckner JH, Keating RM, Costenbader KH, Gregersen PK, Weisman MH, Mikuls TR, O’Dell JR, Holers VM, Norris JM, Karlson EW. Associations of Smoking and Age With Inflammatory Joint Signs Among Unaffected First-Degree Relatives of Rheumatoid Arthritis Patients: Results From Studies of the Etiology of Rheumatoid Arthritis. Arthritis Rheumatol. 2016 Aug;68(8):1828-38. PMID: 26866831; PMC5103164.
  7. Sieberts SK, Zhu F, García-García J, Stahl E, Pratap A, Pandey G, Pappas D, Aguilar D, Anton B, Bonet J, Eksi R, Fornés O, Guney E, Li H, Marín MA, Panwar B, Planas-Iglesias J, Poglayen D, Cui J, Falcao AO, Suver C, Hoff B, Balagurusamy VSK, Dillenberger D, Neto EC, Norman T, Aittokallio T, Ammad-Ud-Din M, Azencott CA, Bellón V, Boeva V, Bunte K, Chheda H, Cheng L, Corander J, Dumontier M, Goldenberg A, Gopalacharyulu P, Hajiloo M, Hidru D, Jaiswal A, Kaski S, Khalfaoui B, Khan SA, Kramer ER, Marttinen P, Mezlini AM, Molparia B, Pirinen M, Saarela J, Samwald M, Stoven V, Tang H, Tang J, Torkamani A, Vert JP, Wang B, Wang T, Wennerberg K, Wineinger NE, Xiao G, Xie Y, Yeung R, Zhan X, Zhao C, Greenberg J, Kremer J, Michaud K, Barton A, Coenen M, Mariette X, Miceli C, Shadick N, Weinblatt M, de Vries N, Tak PP, Gerlag D, Huizinga TWJ, Kurreeman F, Allaart CF, Louis Bridges S Jr, Criswell L, Moreland L, Klareskog L, Saevarsdottir S, Padyukov L, Gregersen PK, Friend S, Plenge R, Stolovitzky G, Oliva B, Guan Y, Mangravite LM. Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis. Nat Commun. 2016 Aug 23;7:12460. PMID: 27549343; PMC4996969.
  8. Harris HR, Costenbader KH, Mu F, Kvaskoff M, Malspeis S, Karlson EW, Missmer SA. Endometriosis and the risks of systemic lupus erythematosus and rheumatoid arthritis in the Nurses’ Health Study II. Ann Rheum Dis. 2016 Jul;75(7): 1279-84. PMC4740245.

 

Back To Top